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Graphical Abstract 
A. Probe Study 
 
 
 
 
 
 
 
 
 
 
1. The research is based on the finding of the reversible transformation of the weakly 
fluorescent europium-tetracycline complex (EuTc) to highly fluorescent europium-
tetracycline-hydrogen peroxide complex(EuTc-HP) in neutral pH(see figure above). 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. EuTc and EuTc-HP have shown not only merits that have made the lanthanide labeling so 
versatile in bioanalysis, such as large Stokes shift, line-like emission (spectra, above), µs 
range lifetime, but also compatibility with blue diode laser, as a H2O2 fluorescent probe. 
3. EuTc and EuTc-HP have been characterized through absorbance, circular dichroism, 
fluorescence, pH response, temperature response, stability, and etc. 
4. A combinatorial approach for discovery of new lanthanide probes has been tested. 
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B. Assay Study 
1. Substrate determinations 
The substrates detected in this study are hydrogen peroxide, glucose as an example 
of the substrates of oxidases (see figure below, a time trace of GOx + glucose with EuTc). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Enzyme analysis 
Glucose oxidase (GOx) is studied in this thesis as a model enzyme of H2O2 
producing oxidases, and catalase (CAT) as a model enzyme of H2O2 consuming enzymes. 
3. Different schemes of detections 
Steady-state intensity-based detections, time-resolved “gated” detections (see figure 
below), and lifetime-based detections of rapid lifetime determination method and time-
correlated single photon counting method have been studied in both microplates and cuvettes. 
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C. Imaging Study 
“Seeing is believing”. Visualization through imaging is a better way for bioanalysis 
(the image below showing “Glu” as glucose). The µs range lifetime of the fluorescent probes 
has greatly facilitated the imaging here. 
 
 
 
 
 
 
 
1. Four schemes of imaging (see figure below), that are the conventional fluorescence 
intensity imaging (FII), the time-resolved ("gated") imaging (TRI), the phase delay ratioing 
imaging (PDI), and the rapid lifetime determination imaging (RLI), have been used for 
quantitative analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2. Hydrogen peroxide, glucose, and glucose oxidase have been determined by the fluore-
scence imaging system developed. 
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D. Further Applications 
 
1. GOx-ELISA, both in sandwich and direct scheme, has been tested without coupling POx. 
2. In preliminary studies for arrays and sensors, biotinylated GOx is immobilized on the 
streptavidin-coated microplates for the quantitative measurement of glucose and for the deter-
mination of immobilized GOx (see figure below). It is for multi-enzyme arrays and sensors, 
which can detect multi-substrates simultaneously on a single shot with microplate arrays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. A platform composed of the coupled CAT/GOx system has been constructed for the 
screening of antioxidative substances and as an alternative for H2O2-independent 
measurement of CAT. The performance of the coupled enzymatic system can been seen in the 
following figure. The imaging can also be applied for this purpose. 
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Chapter 1. Introduction 
1.1. Importance of Hydrogen Peroxide 
Hydrogen peroxide (H2O2) is relatively simple molecule as shown in Figure 1.1. 
However, it is considered as a ubiquitous molecule in almost every aspects of our life, mainly 
due to the adaptation of nature to the unusual high concentration of oxygen in atmosphere of 
the earth1. 
 
 
 
 
 
 
 
Figure 1.1 Structure of hydrogen peroxide. 
Although there are a lot of household and industrial applications2,3,4,5 for hydrogen 
peroxide, the biologically originated hydrogen peroxide is more important and more 
challenging for bioanalysis. It is of enormous significance in biomedical research for its 
central role in oxidative stress and peroxidation in general. H2O2 as one of the reactive oxygen 
species (ROS)6,7 is viewed as a biomarker for the oxidative stress in cells and as a novel 
neurotransmitter8,9. The common ROS, their inter-transformation and their energy levels are 
indicated in Figure 1.2. As a metabolic species produced by almost all oxidases and SOD, and 
as a substrate for catalase and peroxidases, hydrogen peroxide is acting as a messenger for 
signal–transduction10,11 that regulates cell growth and reduction-oxidation status12. It is also a 
potentially harmful metabolic by-product in the presence of metal ions (production of 
hydroxy radicals through Fenton reaction13,14) that can cause DNA damage15,16 and has direct 
(mostly adverse) effects on cell survival, aging, and cancer development17. 
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Figure 1.2 Common reactive oxygen species and their energy level. 
1.2. Overview of Hydrogen Peroxide Based Enzymatic Assays 
Enzymes, as highly specific catalysts in mild reaction conditions, have been used in 
the diagnosis of disease and bioanalysis for quite a long time. There are lots of reports, 
reviews and books on their characterization and applications18,19,20. Enzymes have been 
applied either for the specific detection of enzyme substrates21,22, or for enzymatic 
amplification immunoassays for biologically important molecules23, such as antibodies, 
antigens, nucleic acids, or environmental hazards. 
As in Figure 1.3, enzymes, enzyme substrates and enzyme inhibitors can be 
determined via detectable substrate, products, enzyme cofactors of coenzymes, prosthetic 
groups and metal ions, and even enzyme itself through the intermediate states if the 
electrochemical, spectrophotometric, fluorescent, chemiluminescent signals are generated. For 
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interests of the present research, there have been reports based on fluorescent products, such 
as resorufin24,25 or fused green fluorescent protein (GFP) receptors26; fluorescent cofactors, 
such as NADH27; fluorescent substrates28,29, such as fluorescein monophosphates30 or other 
fluorescent peptides31; or coupling enzymes32 for the fluorogenic purposes, such as 
peroxidases (POx). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Principles for enzyme and enzyme substrate determination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Two schemes for enzymatic amplification. 
Enzymes for enzymatic amplification are mainly peroxidase, alkaline phosphatase, 
and β-galactosidase, basically for their high activity and stability. Catalase and glucose 
oxidase are also sometimes used. There are generally two schemes for enzymatic 
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amplification as shown in Figure 1.4. One (Figure 1.4 A) is for the amplification reaction of 
the substrate, while one single enzyme can catalyze multiple substrates into as much as 
possible detectable products for the measurement of a single analyte. The other is based on 
the cofacters (Figure 1.4 B) that can be detected by formation of the holo-enzyme, which 
could generate as much as possible detectable products. 
 
Among different detection schemes (as in Figure 1.3) mentioned above, hydrogen 
peroxide is of great interests for the following reasons: 
(1) There are numerous H2O2 producing oxidases available for the quantitative analysis 
of biochemically important molecules of clinical interests33, such as glucose, urate, 
sarcosine, urea, lactate, etc. 
(2) As a product of enzyme reactions, H2O2 does not form a signal background in most 
biological media. 
(3) There are a variety of cascade enzyme reactions related to H2O2 available for the 
detection of otherwise difficult to detect species, such as creatinine, creatine, etc. 
Even some NADH related cascade reactions can be further linked with H2O2 by 
NADH oxidase43. 
(4) H2O2 consuming enzymes, such as peroxidase, catalase, etc, are usually of high 
enzyme activity and stability suitable for the enzyme amplification. 
In fact, H2O2-related bioassays are of great significance for enzyme substrates, cofactors, 
enzymes, nucleic acids and cells, as summarized in Table 1.1. 
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Table 1.1 Application of H2O2 assay in biological assays. 
 Target Methods Note Ref 
Glucose Chemilum. + POx in urinary and blood 34 
L-Lysine Chemilum. Lysyl oxidase + peroxidase 35 
Urate (uric acid) Chemilum. Uricase + Luminal + Fe3+ 36 
Acetylcholine Fluorescent Acetylchilinesterase + choline oxidase 37 
Lactate Fluorescent Lactate oxidase 38 
Glutamate Fluorescent Glutamate oxidase 39 
Sphingomyelin Fluorescent Sphingomyelinase + Alk.phosphtase  + Cholineoxidase 
40 
Sarcosine Fluorescent Sarcosine oxidase 41 
Enzyme 
substrates 
Cholesterol Amperometric  42 
Cofactors NADH(NADPH) Fluorescent NADH oxidase 43 
Glucose oxidase Fluorescent + POx 34 
Amine oxidase Fluorescent Spectrophotometric 44 
Catalase Fluorescent  45 
Enzymes 
Peroxidase Chemlum.  46 
Nucleic acids Peroxidase Chemlum. Peroxidase amplification 47 
Cells  Fluorescent  98 
 
1.3. Overview of Methods for Determination of Hydrogen Peroxide 
In general, H2O2 on its own is thermodynamically reactive, but kinetically relatively 
poorly reactive (Figure 1.2). It can act both as a mild oxidizing and reducing reagent. Unlike 
the others of reactive oxygen species, H2O2 needs to be activated for the common oxidative 
reactions in biological systems. Usually only under the activation of transition metals or 
enzymes containing transition metals, H2O2 shows its reactivity. The chemical characteristics 
of H2O2 in this respect consequently made it rather difficult to detect than its brothers of the 
reactive oxygen species, such as superoxide and hydroxyl radicals. 
Chapter 1. Introduction 
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1.3.1. Analytical Methods Based on Physical Properties 
Numerous methods have been developed for H2O2 determination. There are a variety 
of electrochemical, optical, thermal, ultrasonic, chromatographic methods, even mass spectra 
method48, having been reported for H2O2 quantitation. Among the electrochemical methods, 
amperometry is widely used for direct and continuous analysis of H2O2 if no other similar 
electroactive species are present49. Furthermore the optical methods by UV detection at  
240 nm50,51 and mid-IR detection52 at 1200 to 1500 cm-1 or 2600 to 3600 cm-1 can also 
achieve direct and continuous monitoring of H2O2, if there are no interferences in the matrix. 
Since most of H2O2 is produced in a biological media, these direct methods based on physical 
properties of H2O2 (as summarized in Table 1.2) are rather restricted by their relatively poor 
robustness and sensitivities for biomedical applications. 
Table 1.2 Analytical methods based on physical properties of H2O2 
Method LOD  Dynamic range pH Note Ref. 
UV absorbance ~ mM / 7.0 240 nm,  ε=43.6 mol-1 L cm-1 50,51 
IR spectroscopy ~1% 1-10% (w/w) / Peak area or height at 1530-1260 cm-1 or at 2930-2680 cm-1 
52 
Raman scattering / / / Peak area or height 800-920 cm-1 53 
ESR / / / / 54 
H2O2 amperometry 2x10-7 M 2x10-7-1.1x10-3 5.5 0.0V vs. SCE 49 
 
1.3.2. Optical Analytical Methods Based on Chemical Reactions of H2O2 
Alternatively, indirect, usually irreversible reaction-based methods have been 
exploited for the sensitive determination of H2O2. Among them, optical methods, including 
spectrophotometric, fluorometric, chemiluminescent methods, are mostly used and offer the 
variety and sensitivity for the biologically originated H2O2. These derivation methods can be 
Chapter 1. Introduction 
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categorized into following three approaches: (1) based on simple oxidations; (2) based on 
enzyme coupling with peroxidases; (3) based on metal H2O2 complex. 
Table 1.3 Analytical methods based on simple oxidations of H2O2 
Method LOD (mol L-1) 
Dynamic range 
(mol L-1) pH Reaction & Note Ref 
Chemilum. 0.42x10-9 0.42-300x10-9 10.2 Luminol + H2O2 + Co2+, for seawater 64 
Chemilum. 25pptv 25pptv-100ppbv 10.8 Luminol + H2O2 + Co2+ sensor for gas 55 
Chemilum. 1.0x10-3 3.5-9.0x10-3 ~10 Luminol + H2O2 + Fe
3+ sensor for 
immunoassay 
56 
Chemilum. / 0.5-100x10-3 / Luminol + H2O2 + Co foil sensor 57 
Chemilum. 1x10-7 / / Luminol + H2O2 + Co2+ sensor 58 
Chemilum. 1x10-7 2.0x10-7-1x10-4 8-9 Periodate + H2O2 + Co
2+ sensor for 
rainwater 
59 
Fluoresc. / 0-250 ng/10mL / HMPQ + Co 60 
Fluoresc. 2.2x10-8 2.3x10-7-2.3x10-5 / DTQ 61 
Fluoresc. / 0.1 –10.0x10-3 / O2 Based sensor 62,63 
Spectroph. / millimolar / Microplates 77 
 
1.3.2.1. Determination based on simple oxidations 
The oxidative reaction of H2O2 to oxygen (Eq. 1.1) has been applied for the analysis 
of H2O2 to generate detectable products for optical detections (Table 1.3). 
2222 22 OOHOH
Catalyst + → ………………………………….Eq. 1.1 
As one of the most sensitive optical analytical methods64,65, chemiluminescence 
assays are based on the luminol-H2O2 reaction in basic solution with Co2+, Cu2+, Fe2+ or other 
metal ion catalysts66, with some variations of luminescent substrates, such as periodate67, 
acridinium ester68. Subnanomolar H2O266 determination has been achieved despite this 
method is usually restricted by its strongly basic pH. 
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Alternatively, fluorescent determination has been applied to H2O2 based on the 
oxidation69. The generation of oxygen can be measured by the oxygen-sensitive fluorescent 
probes, such as derivatives of Pd or Pt porphyrins70, or directly by oxygen optical sensors71. 
Another approach is mainly based on the ROS fluorogenic reactions72, especially for 
fluorescent imaging in biological samples. For example, the general oxidation by H2O2 of 
dichlorofluorescin, dihydrorhodamine and hydroethidine into their oxidized form which are 
highly fluorescent73,74 (Figure 1.5). The most recent advance in this category is the reports 
based on the fluorescence change of the green fluorescent proteins upon the reaction of H2O2 
or other ROS75. However, these methods usually are not H2O2 specific and prone to 
interferences by other ROS species. In addition, most of the reactions are supposed to happen 
under peroxidase74 available in biological samples. 
 
 
 
 
 
 
 
 
Figure 1.5 ROS based scheme via 2´,7´-Dichlorofluorescin. 
There are also many reports based on the spectrophotometry and reflectance, such as 
the decoloration of Prussian blue76, or H2O2 indicator papers or microplates77. Despite their 
convenience, the sensitivity is not usually good enough for the biologically originated H2O2. 
1.3.2.2. Determination based on enzyme coupling with peroxidases 
For the relatively poor sensitivity and selectivity of the methods described above, the 
coupling with POx is introduced for more sensitive and specific H2O2 detection. It is based on 
the specific H2O2 reaction with hydrogen donors on the catalysis of POx (Eq. 1.2). The 
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hydrogen donors (usually phenol derivatives) of POx reaction have been widely explored for 
the chromogenic78, fluorogenic79, and chemiluminogenic80 purposes.  
OHSOHHS Peroxidase 222 2+ →+ ………………………….Eq. 1.2 
HS: hydrogen donor, S: oxidized donor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Three main variations of the POx –aided detection for H2O2. 
There are three main variations for POx–aided detection for H2O2 as manifested in 
Figure 1.6. (The products of the POx reaction are usually quantified, either by 
spectrophotometry, fluorometry, or chemiluminescence, as indicated in Figure 1.6 as 
fluorescent). One (Figure 1.6 A) is based on the fluorescent or color-changing dimer products 
of the hydrogen donors reacting with H2O2 in the presence of peroxidase, such as 
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homovanillic acid and derivatives in the earlier reports by Guilbault and co-workers81,82; or 
Trinder reagent83, such as 2-hydroxy-3,5-dichlorobenzesulfonate. Another (Figure 1.6 B) is 
based on the catalytic de-acetylation of the hydrogen donors, such as Amplex Red84 and 
Scopoletin85. The last (Figure 1.6 C) is based on recently reported enzyme-amplified 
lanthanide luminescence (EALL)86, through the long-decaying fluorescent lanthanide 
complexes formed by the dimeric products of the reaction87. 
Table 1.4 Analytical methods for H2O2 based on enzyme coupling with peroxidases 
Method LOD Dynamic range Reaction Ref 
Chemilum. 1 nM 5 nM-5mM Luminol + H2O2 + POx sensor 88 
Chemilum. 52.2 µM / Luminol + H2O2 + POx sensor 89 
Chemilum. 40 nM 0.1 µM-0.2 mM Luminol + H2O2 + POx sensor 90 
Fluoresc. 50 nM / POx + Amplex Red, Exc/Em: 530/590 nm 91 
Fluoresc. / 9 nM-1µM POx + resorufin, pH 6.4 92 
Fluoresc. 2–10 nM / POx + Scopoletin Exc/Em: 390/460, pH 8.5-9.5 93 
Fluoresc. 2 pmol 0.1-2 nmol POx + A6550, Exc/Em: 360/460, 590/645, pH7.4 94 
Fluoresc. 1.4 nM 0.0-0.2 µM POx + cyanine 95 
Fluoresc. / ~44 nM-440 nM POx + Homovanillic acid, Exc/Em: 312/420 nm 96 
Spectroph. 4 nM 20-700 nM DAP, 590 nm absorbance 78 
Spectroph. / 0.1-300 mg/L 4-chloro-1-naphthol 97 
 
Although chemiluminescence or electroluminescence can also used for determination 
of H2O2 with extreme high sensitivity based on peroxidase reaction (usually performed at pH 
above 8), and spectrophotmetric methods has been developed for the simplicity of the 
instrumentation97, fluorometry is mainly used for biological samples. It is due to its similar 
sensitivity, reproducibility and optimal neutral pH, in measurements with certain phenols. The 
characteristics of POx-based optical assays for H2O2 are summarized in Table 1.4. The recent 
development is for the wider application for in vitro and in vivo detections98 and using of POx 
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mimetics, such as Mn porphyrin, homoglobin, hemin, Fe calixerene, etc99, to overcome the 
relative instability of the POx protein. 
1.3.2.3. Determination based on metal H2O2 complexes 
From the early development of analysis of transition metals, ternary complexes of 
transition metal ions (mainly vanadium and titanium) with H2O2 have long been recognized 
for their potential application in the H2O2 analysis. The intramolecular energy transfer from 
the ligands to central metal ions is considered as a smallest metal-antenna system of energy 
transfer. Although the exact mechanism for the detection is not really clarified from the 
possible two mechanisms (free-radical mechanism or peroxide complex mechanism100), there 
have been several reports of H2O2 assays based on this kind of ternary complexes as 
summarized in Table 1.5. 
Table 1.5 Analytical methods based on metal H2O2 complexes 
Method LOD  Dynamic range Reaction Ref. 
Fluoresc. 0.05 µM 0.2-50 µM Vanadium (V
4+ or V5+) +PTQA+H2O2, 
340/490nm, in H2SO4 
101 
Spectroph. / 10-150 ppm Vanadium (V
4+ or V5+) 450 nm in 0.6-6 N 
H2SO4 
102 
Spectroph. 1 µM 4 -60 µM titanium(IV) peroxo complex 410 nm 103 
Spectroph. 0.25 µM / Ti (IV)+H2O2 + PAR 104,105,106 
Spectroph. / / Decoloration of Ti(IV)- complex at 610 nm 107 
Fluoresc. 1.8 µM 2-400 µM Europium-tetracycline complex 108 
 
The earlier studies are mainly photometric methods based on the formation or 
decoloration of the colored vanadyl complex or the titanium(IV) peroxo complex with H2O2. 
The further development is the introduction of second ligands, such as PAR, to increase the 
spectrophotometric sensitivity or the search for fluorescent ligands. However, the available 
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metal-H2O2-ligand complex systems are usually in strong acidic range (e.g. 0.15 M H2SO4). 
While the complexes formed usually are at high acidity, the ternary complexes of metal ion, 
organic ligand, and H2O2 can shift the optimal pH to weak acidic pH, such as 5-6. 
Only recently, it has been reported by our group of a new europium-tetracycline-
H2O2 system in the neutral range (optimal pH 6.9)108. This system has also introduced the 
characteristic lanthanide fluorescence, such as long Stokes’ shift, long lifetime (tens of µs 
range), which offers great potential for hydrogen peroxide based enzymatic assays for 
enzymes, enzyme substrates or enzyme inhibitors, especially in combination with the time-
resolved fluorometry and imaging. 
1.4. Time-resolved Fluorescence Assays and Imaging 
Compared with other optical techniques, fluorometry for enzymatic assays has one 
advantage, if not more, of multiple parameters available for the measurement. There are 
mainly two different approaches for fluorometry, based on either spectral or temporal features 
of the fluorescence emissions109. Steady-state fluorescence techniques were developed first on 
the basis of differences of their spectra: peak positions, intensity, excitation, anisotropy, etc. 
This approach is still widely used in biomedical analysis. But this approach has the following 
disadvantages: (1) Excitation at UV and visual region of most fluorescent probes results in 
background fluorescence, despite novel development in near infrared fluorescent probes. (2) 
The fluctuation of the light source has significant effect on the final intensity readouts. (3) the 
amount of fluorophores and therefore photobleaching affect the determination. (4) The 
overlapping of the broad emission spectra of most fluorophores can cause interferences, and 
restrict their applications in multiplexed assays and imaging. 
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A different approach is the investigation of the temporal properties of the 
fluorophores110. The time-resolved gated fluorescence assay111 was the first applied as a time 
delay approach for their simplicity. Gated fluorometry is a method for measurement of 
fluorescence intensity as a function of analyte concentration. The measurement is proceded 
only after the background  fluorescence (lifetime < 20 ns) has ceased, while the fluorescence 
decay of the probe (lifetime > 1 µs) is still going on. It has the specific feature of enabling the 
suppression of potentially interfering background fluorescence. However, it still depends on 
the amount of fluorophores presented, photobleaching and the fluctuation of the light source. 
In contrast to gated fluorometry, the lifetime fluorometry112, either phase-domain or 
time-domain, is a method for measurement of fluorescence lifetime as a function of analyte 
concentration. The fluorescence lifetime is pre-determined by the nature of the fluorescent 
probe and only sensitive to the micro-environment around the fluorophores. Therefore, the 
measurements are usually independent of (1) interfering fluorescence from the background; 
(2) The fluctuation of the light source; (3) amount of fluorophores and photobleaching. So 
lifetime detection has been becoming a superb techniques for enzymatic analysis. 
Nowadays, the widely used adage that `seeing is believing' is as true today as it has 
ever been, with the development of different imaging technologies, such as fluorescence 
imaging113, magnetic resonance imaging114, or ultrasonic imaging115. Optical imaging 
methods have not only attracted attention in life sciences, but also become more and more 
important for practical processes in bioanalysis and clinical diagnostics116. The combination 
of fluorescence analysis with imaging represents a useful tool in such diverse applications as 
mapping of biological samples, or monitoring biological reactions and interactions, especially 
those in high-throughput screening modes. The fluorescence imaging is certainly preferred 
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whenever the localization of any fluorophore is required. The two dimensional measurement 
provide more information than the point spectroscopy. It offers the ability to visualize the 
distribution of the fluorophores and the newly developed array technologies117 also requires 
the 2D imaging to offer multi-substrate and multi-enzyme detection118. Same as the point 
fluorescent detection, the fluorescence imaging is now also achievable by either spectral or 
temporal approach. Different schemes of fluorescence imaging, such as conventional 
fluorescent intensity imaing, gated imaging and fluorescence lifetime imaging have offered 
plenty of possibilities for the bioanalysis, which is the main target of the present research. 
1.5. Aim of the Research 
The goal of this thesis is, on the basis of a new europium fluorescent probe for 
hydrogen peroxide, to develop quantitative assays for enzymes and enzyme substrates, in a 
time-resolved microplate format and imaging format. 
Firstly for the probe study, the complete characterization of the fluorescent probe 
EuTc and EuTc-HP will be done. The structure of EuTc-HP is also of high interest for the 
discovery of new lanthanide probes. 
The second is assay development. Assays for oxidases and their substrates and H2O2 
consuming enzymes (such as catalase), are intended for the steady-state intensity-based, time-
resolved gated and lifetime-based fluorescent detection. 
Thirdly, imaging formats have been developled for the two dimensional 
measurement of the assays.  
The last is the further applications of the fluorescent probes, such as for ELISA, for 
the sensor and microplate-based array construction. 
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Chapter 2. Characterization of the Fluorescent Europium Probe 
                  and Time-resolved Fluorescent Assay of Hydrogen Peroxide 
2.1. Introduction 
As described in Chapter 1, the importance of biologically originated H2O2 detections 
has been generally recognized for their applications in developments of biological assays for 
enzyme substrates, for enzyme inhibitors, for enzymes, and also for enzymatic amplification 
immunoassays1,2. Among the numerous methods, fluorescence based assays3 have been 
mainly used in biological applications for their good sensitivity and selectivity. Furthermore, 
besides the conventional steady-state intensity-based assays, fluorescence determination can 
also be achieved through other schemes, such as anisotropy polarization, time-resolved and 
recently time-resolved anisotropy assays. These techniques provide more approaches for 
improvement of the sensitivity and the selectivity in complicated biological backgrounds over 
other optical methods. Since H2O2 is a small and simple molecule, its anisotropy 
determination seems to be very difficult. However, the time-resolved assay for H2O2 is still 
possible due to recent developments in lanthanide fluorescence. 
There are a lot of time-resolved assays4,5 for enzymatical analysis, such as DELFIA6, 
EALL7,8, etc. However, only few research on the direct time-resolved determination of H2O2 
are reported. Karst9 has reported a scheme for H2O2 determination based on the EALL 
method. The approach utilizes the products of POx-catalyzed H2O2 reaction to form a terbium 
complex which has the characteristics of lanthanide fluorescence and consequently can be 
applied for the time-resolved assay of H2O2. The significance of time-resolved fluorometry of 
H2O2 is that it can usually greatly suppress the background fluorescence from biological 
Chapter 2. Characterization and Time-resolved Measurement of H2O2 
 25 
samples and increase sensitivity, in addition to the selectivity improvement over the lifetime 
characteristics. Despite the unbeatable high sensitivity, this method needs further steps for 
fluorescence development by enhancing solution and usually in extreme basic (i.e. pH ~13) 
conditions for the formation of the lanthanide complexes, especially those related to H2O2. 
In this thesis, a fluorescent probe based on europium tetracycline complex has been 
further characterized and applied for a time-resolved fluorescent determination of H2O2. The 
probe has shown not only merits that have made the lanthanide labeling so versatile in 
bioanalysis10,11, such as large Stokes shift, line-like emission, µs lifetime range, but also 
compatibility with the 405 nm blue laser diodes, and sensitive to H2O2 as a fluorescent probe 
with a optimal pH of 6.9. The time-resolved “gated”, and lifetime-based time-correlated 
single photon counting detection (TCSPC)12 have been exploited. Furthermore, a lifetime-
based rapid lifetime determination method13,14,15 has been borrowed from the fluorescence 
lifetime imaging microscopy (FLIM)16 for the on-the-fly measurements of lifetimes on the 
microplate for H2O2 determination. 
2.2. Results and Discussion 
2.2.1. Characterization of the Fluorescent Europium Probe 
2.2.1.1. Absorbance, circular dichroism and fluorescence spectra 
The absorbances of EuTc and EuTc-HP are quite similar as indicated in  
Figure 2.1 (A) and Table 2.1. The absorption band (with peaks at 392 and 401 nm) is caused 
by the presence of the tetracycline ligand which, in its uncomplexed form, has a slightly blue 
shift absorption spectrum. The cicular dichroism spectra of EuTc and EuTc-HP are offered in 
Figure 2.1 (B). There are a positive cotton effect at 400 nm and a negative cotton effect at 320 
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nm different from the circular dichroism spectra of Tc alone, with some other four positive 
cotton effects from 200 – 300 nm. Few difference is observed in the circular dichroism of 
EuTc and EuTc-HP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Spectra of EuTc and EuTc-HP. 
(A) Absorbance spectra of EuTc and EuTc-HP; (B) Circular dichroism spectra of EuTc and EuTc-HP. 
Table 2.1 Spectral characterization of EuTc and EuTc-HP 
 EuTc EuTcHP 
Peaks (nm) 392 401 391 401 
Molar absorbance 
 ε (cm-1 M-1) 1.88x104 1.88x104 1.78x104 1.73x104 
Max. Emission (nm) 617 613 and 619 
Quantum Yield (%) 0.3 4.0 
 
The fluorescence spctra and absorbance spectra of EuTc and EuTc-HP are shown in 
Figure 2.2. As in other complexes of this type, the photonic energy absorbed by the ligand is 
transferred from the triplet state of the ligand to the central Eu3+ ion with its typical emission 
spectra17 of a main band which peaks at 617 nm (5D0→7F2) and several side bands centered at 
579, 597, 654, and 688 nm, respectively. Quantum yield of EuTc-HP is 4.0%, while that of 
EuTc is 0.3%, with tris(2,2'-bipyridyl)dichlororuthenium(II) hexahydrate (TBDRH) as 
reference18. The fluorescence intensity of EuTc-HP is up to 15 times that of EuTc. 
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Figure. 2.2. Absorption spectra (left) and emission spectra of EuTc and EuTc-HP. Fluorescence 
spectra were acquired with the AB2 spectrofluorometer and show two peaks. To 2 mL of a solution 
containing Eu3+ (102 µmol L-1) and Tc (34 µmol L-1) were added 200 µL of a 5 µmol L-1 solution of 
H2O2 and 300 µL of MOPS buffer. Fluorescence was recorded after 10 min. 
2.2.1.2. Lifetime characterization of EuTc-HP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Decay profile of the EuTc probe and its complex with H2O2 (EuTc-HP). The samples 
were prepared by addition of different concentrations (0 for EuTc or 1 mmol L-1 for EuTc-HP) of 
H2O2 to a final concentration of EuTc of 53.3 µmol L-1 and waiting for 10 min before measurement. 
W1: window 1, W2: window 2, as applied for Rapid Lifetime Determination (RLD). 
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The decay profiles of the EuTc and EuTc-HP are shown in Figure 2.3. The decay can 
be fitted into a three-component exponential decay model according to Eq. 2.1, with all 
 1 < χ2 < 1.1 and relative residue of the fitting being symmetric and less than 5%. 
            ……………….Eq. 2.1 
Table 2.2 Lifetime composition of EuTc and EuTc-HP 
 EuTc EuTcHP 
 Decay  time (µs) Rel. Amplititude (%) Decay  time (µs) Rel. Amplititude (%) 
τ1 6.8 39.5 10 17.3 
τ2 24 54.7 34 18.2 
τ3 53 5.9 61 64.5 
Av. 30 µs 60 µs 
 
The lifetime composition of EuTc and EuTc-HP is summarized in Table 2.2. EuTc 
has an average lifetime of 30 µs, while EuTc-HP an average lifetime of 60 µs. 
The average lifetime for multi-component decays can be described in two ways19, as 
in Eq. 2.2 and Eq. 2.3: 
           ……………………….Eq. 2.2 
−
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−
2τ : is proportional to the area under the decay curve 
For the case of a single component decay, 
−
1τ =
−
2τ . For multi-component decays like 
EuTc and EuTc-HP, they are different and 
−
1τ  is used throughout, unless otherwise specified, 
∑
∑
=−
i
ii
i
ii
A
A
τ
τ
τ
*
* 2
1
∑
∑
=−
i
i
i
ii
A
A τ
τ
*
2
∑
=
− +=
n
i
t
i BeAtI i
1
1
/)( τ
Chapter 2. Characterization and Time-resolved Measurement of H2O2 
 29 
since the average amount of time the fluorophores remain in their excited state after excitation 
is more adequate than just the integration of the area under the decay curves. 
Because of the complexity of the multi-component decays of EuTc and EuTc-HP, the 
decay profiles were further studied for the rate constant (k) distributions of Gaussian ln (k) 
model according to Eq. 2.4. The result is provided in Figure 2.4. The increasing concentration 
of H2O2 resulted in the shift of the distribution from the faster decay to a slower decay. 
    ∫ += −
k
tk BdkektI 1)()( ρ  …………………..Eq. 2.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. Rate constant (k) distributions of Gaussian ln (k) model. 
 In the same experimental condition as in Figure 2.2. 50 µs as the most frequent lifetime for EuTc-HP, 
19 µs as the most frequent lifetime for EuTc. 
2.2.1.3. pH, buffer, temperature and stability 
The effect of pH on the fluorescence intensity of EuTc-HP was also studied (Figure 
2.5). The emission intensity of EuTc-HP is strongest at pH 6.6 – 7.2, and rapidly drops 
outside this range. In fact, it is only 15% of the maximal intensity at pH 8.0, and 8% at pH 
6.0, with the optimum pH at 6.9. 
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Figure 2.5. The pH optimization for EuTc-HP complex system. 90 µl of 0.2 mmol L-1 EuTc, H2O2: 
240 µmol L-1 and 12 mmol L-1 MOPS buffer solution (pH 6.9) in 2000 µl cuvette. 
The effect of MOPS, Tris, HEPES and phosphate buffers can be seen in Figure 2.6. 
Phosphate interferes most strongly, while HEPES has a slight quenching effect. Tris buffer 
does not significantly affect fluorescence, however its best buffer capacity is between pH 7.5 
and 9.0 and thus outside the preferred pH range. MOPS buffer is the optimal. Therefore, a 10 
mmol L-1 MOPS buffer of pH 6.9 was used throughout the experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6. Buffer effect on EuTc-HP complex system. 90 µl of  0.2 mmol L-1 EuTc, 
 H2O2: 240 µmol L-1 and 12 mmol L-1 MOPS buffer solution: pH 6.9 in 2000 µl cuvette. 
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The temperature effect on the EuTc-HP is also investigated in Figure 2.7. An 
increase in temperature results in a decrease of the fluorescence. This is in accordance with 
the common properties of fluorophores.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7. Temperature effect on EuTc-HP complex system. EuTc 80 µmol L-1, 
 H2O2 400 µmol L-1, MOPS to 2 ml. Thermostated at the temperature for 30 min before measurement. 
The stability of the EuTc and EuTc-HP were tested. EuTc has shown quite good 
stability as seen in Figure 2.8. The stability is indicated by the change of the absorbance. 
Within 45 days, there is only a small deviation less than 1.6%. EuTc-HP is not as stable as 
EuTc. It is prone to decomposition, but usually stable for more than 4 hours as shown in the 
time trace of the fluorescence in Figure 2.9, with a constant baseline shift. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8. The stability of EuTc complex as indicated by the absorbance change. 
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Figure 2.9. The stability of EuTc-HP complex as indicated by the fluorescence change. 
 60 µmol L-1 EuTc in MOPS (10 mmol L-1, pH=6.9) in the wells, H2O2 400 µmol L-1 in the wells. 
2.2.1.4. Quenchers and interferents 
The possible interferences by common anions and cations are also explored (Figure 
2.10). The fluorescence of the EuTc-HP complex system is not affected by alkali, alkali earth 
and ammonium ions, nor by anions including chloride, bromide, iodide, sulfate and nitrate in 
up to ~100 mmol L-1 concentrations. Fluoride acts as a weak quencher if present in a 
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concentration higher than 0.1 mmol L-1. However, phosphate, copper(II) and iron (III) ions 
are strong quenchers of the system. Furthermore, the fluorescence of the EuTc-HP system is 
weakly quenched by molecular oxygen. An 11% decrease in fluorescence intensity was 
observed on going from nitrogen-saturated solutions to air-saturated solutions. 
2.2.2. Time-resolved Fluorescent Determination of Hydrogen Peroxide 
2.2.2.1. Time-correlated single photon counting (TCSPC) method 
Time-correlated single photon counting (TCSPC) method is one of the mostly used 
methods for photon-counting lifetime detection. This method can be applied for the 
determination of H2O2 with the EuTc fluorescent probe. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11. A: Three component mode of the decay vs the concen. of H2O2 in amplitudes. B: the 
mainly changed component in amplitudes (Component III, ~60 µs) vs the concen. of H2O2. The 
samples were prepared by addition of different concentrations (0 - 1000 µmol L-1) of H2O2 to a final 
concen. of EuTc of 53.3 µmol L-1 as respect to tetracycline and waiting for 10 min before detection. 
As shown in Figure 2.11, the three components of the decay were correlated with the 
concentrations of H2O2. The mainly changed component is component III. The determination 
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of H2O2 can be achieved through the amplitude of component III. The dynamic range is from 
0 to 500 µmol L-1(Figure 2.11 B). For the simplicity, the average lifetimes in different H2O2 
concentration can also be utilized for the determination of H2O2 as in Figure 2.12. The 
dynamic range is narrower than the mainly changed component method and ranges from 0 to 
100 µmol L-1. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.12. Calibration of H2O2 in average lifetimes. The samples were prepared by addition of 
different concentrations (0 - 1000 µmol L-1) of H2O2 to a final concentration of EuTc of 53.3 µmol L-1 
as respect to tetracycline and waiting for 10 min before measurement. 
2.2.2.2. Rapid lifetime determination (RLD) method 
Despite the ability of determination of H2O2 by the TCSPC method, it is rather 
complicated both from the instrumental aspects and the data processing aspects. For these 
reasons, it is mainly used for characterization of the fluorophores rather than quantitative 
detections. To overcome the relatively tedious procedure of photon counting, there have been 
several approaches to simplify both the instrumentation and data processing procedure 
[PDI20,21, and RLD22,23]. Among them, the rapid lifetime determination method (RLD) has 
been quite thoroughly studied as an alternative for the accurate lifetime determinations, such 
as the TCSPC method. Unlike TCSPC, RLD detects only two windows in the decay and uses 
the ratio of the two windows (see Figure 2.2) as an indication of the lifetime as widely used 
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for imaging, especially helpful for the on-the-fly detection. Here a RLD method is presented 
for the determination of H2O2 on a commercially available microplate reader. 
The most favorable experimental conditions were obtained by stepwise optimizations 
of the delay time, integration time and RLD windows. The best delay time was found to be 
~60 µs. The integration time have no signification effect and 40 µs was selected for the 
detection. The selection of the measurement windows was optimized for the different 
concentrations of EuTc and different windows, as schematically indicated in Figure 2.3. As 
from Figure 2.13, among all the windows selected for RLD, the ratio of window 1 (60-100 
µs) to window 2 (200-240 µs) has the highest value and still the relative standard deviation is 
less than 5%. So these two windows were selected for the RLD determination of H2O2 on the 
microplate reader. Data were obtained with 100 times repetition for each data points. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13. Optimization of the measurement windows for the rapid lifetime determination 
method. The samples were prepared by addition of different concentrations (for each cluster from left 
to right, 120, 100, 80, 40 µM) of EuTc as respect to tetracycline in the same concentration of H2O2 of 
20 µM. The measurement was performed in triplicate as detected with different windows. 
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The calculation of the RLD method is based on Eq. 2.5. The calibration graph of 
RLD method is demonstrated in Figure 2.14. The curve can be described as y = 7.93 + 0.26 * 
x (r = 0.99, each point in triplicate), with a dynamic range of 5.2 - 50 µmol L-1, and the limit 
of detection (3*SD/Slope) of 5.2 µmol L-1. The limit of detection is not improved over the 
gated methods25 and even intensity-based steady state fluorescent assay26. But it proves the 
applicability of RLD for multicomponent decays and offers the potential for the high 
background determination, such as those of plates and fluorescent proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14. Calibration of H2O2 in Rapid Lifetime Determination (RLD) method. 
See experimental part for the details. 
There have been reports on the theoretical optimization of the RLD windows24, from 
the lifetime data and Monte Carlo calculations. The conclusion from the simulation with 
around 80% overlap of the measurement windows has been tried in this experiment, but with 
relatively low ratio as seen in Figure 2.11. The chosen windows have the highest ratio and in 
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the same time with a less than 5% relative standard deviation. Another aspect that has to be 
taken into account is that EuTc and EuTc-HP are all composed of three-components of decay. 
Although theoretical studies have led to the conclusion of a two-component decay24, the 
optimization of RLD windows might not be suitable for the case used here now. Furthermore, 
the applicability of the RLD method for EuTc and EuTc-HP may also be in doubt due to their 
multi-component decay profiles. However, as suggested by others22, the RLD method may 
still be valid if the monotonic change due to the presence of analyte can be established. 
It should be noted that this is the first example for the RLD method to be applied in 
the microplate assays. The recent developments of fluorescent readers have made it possible 
to detect simultaneously two windows, which will greatly improve the present method. 
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 2.3. Experimental (Please see Chapter 7 for the reagents and instruments) 
2.3.1. Time-correlated Single Photon Counting (TCSPC) Lifetime Determination 
The luminescence lifetimes of EuTc and EuTc-HP were detected with a pulsed 392-
nm laser (LDH-C-400, PicoQuant GmbH, Berlin, Germany; www.picoquant.de), and an 
H5783-P04 PMT detector (Hamamatsu) with a newly developed multiphoton-counting board 
in a special multipass cuvette. The samples were prepared by addition of different conc. (0-
1000 µmol L-1) of H2O2 to a final conc. of EuTc of 53.3 µmol L-1 and waiting for 10 min 
before measurement. Data were processed by the FluoFit software ( from PicoQuant GmbH). 
2.3.2. Rapid Lifetime Determination Assay of Hydrogen Peroxide on Microplates 
Place, in each well of a thermostatted (30 °C) 96-well microplate 100 µL of the EuTc 
stock solution (0.2 mM with respect to Tc), and MOPS buffer to make up the total volume to 
200 µL. The samples (50 µL) containing H2O2 in a concentration between 4 and 200 µM were 
added simultaneously. After 10 min incubation, the rapid lifetime determination scheme with 
two windows of fluorescence intensity detection at 60 µs to 100 µs and 200 µs to 240 µs is 
recorded on the FLUOstar OPTIMA reader. The data are the average of 100 measurements 
for each window for the precision consideration. Control experiments are conducted by 
adding buffer in place of H2O2 samples, to give blank signal denoted as F0. The blank was 
subtracted before the calculation. All microplate experiments were done in triplicate. 
2.3.3. Time-resolved (gated) and Steady-state Fluorescence Assays 
Conventional steady-state and time-resolved “gated“ fluorescence assays were 
performed with the same samples and microplates as described above. 
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Chapter 3. Direct and Time-Resolved Enzymatic Detection of Glucose 
3.1. Introduction 
Glucose is of great importance for its roles in diabetes1, in central carbon 
metabolism2, and in diet-related biomedical research3,4. It is also of interest with respect to 
monitoring industrial processes such as bio-fermentation, brewing, etc5. There have been 
continuous intensive efforts to develop continuous and discontinuous assays, the former often 
with respect to non-invasive, real-time glucose sensors6,7,8. 
Numerous optical (sensory) methods have been proposed. One approach is based on 
the glucose binding capability of concanavalin A (ConA) that can be followed by 
fluorescence resonance energy transfer (measured in either intensity or decay time)9,10. 
However, the method is limited by the tendency of ConA and its conjugate to form 
aggregates. Another more recent approach is based on boronic acid receptors which can 
recognize glucose (and other polyols) and thereby trigger a fluorescent signal11,12,13. A lot of  
efforts have been made to improve the performance of the method, e.g. by making use of an 
aniline/anilineboronic acid copolymer that is capable of binding saccharides and thereby 
undergoes a color change14. Glucose binding proteins conjugated to fluorescent proteins have 
also been investigated with respect to their possible application in glucose assays15,16. 
Despite recent advances, enzymatic methods based on (a) glucose oxidase (GOx) 
that converts glucose and oxygen into gluconate and H2O2, and (b) reduction of glucose by a 
dehydrogenase17 still are the most widely used methods. In GOx-based assays (see Eq. 3.1 
and 3.2), the consumption of oxygen18, changes in pH19 and the intrinsic fluorescence of 
glucose oxidase20 have been exploited, mainly for sensory purposes. 
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glucose + O2   –—(GOx)→   D-gluconolactone  +  H2O2   ……………..Eq. 3.1 
D-gluconolactone  +  H2O   –—→  D-gluconate  +  H+      ……………..Eq. 3.2 
Notwithstanding the utility of these approaches, methods based on the direct 
detection of H2O2 produced (by GOx) according to Eq. 3.1 are of particular interest since 
H2O2 does not form a signal background in most biological matter. Unfortunately, no 
reversible optical indicators (probes) do exist for H2O2. On the other side, H2O2 can be 
irreversibly converted into colored products using peroxidase (POx), thereby enabling single 
shot (irreversible) tests, partially in the form of tests strips for diabetics21,22,23. Chromogenic 
reagents used include, in particular, the so-called Trinder reagents since they can result in 
many different hues of colors22. Guilbault et al.24,25,26 have shown that certain hydroxyphenyl 
acetic acids and homovanillic acid undergo POx-catalyzed oxidative dimerization with H2O2 
to form strongly fluorescent products. These findings forms the basis for widely used and 
very sensitive assays for H2O2 and oxidase-associated enzymatic reactions. 
Few direct methods not requiring POx have been reported. Photometric 
discontinuous assays based on complexes of H2O2 with vanadium27, titanium28,29,30 or ferric31 
ions can be performed, however sometimes not at pH 7 because of the precipitation of the 
respective metal hydroxides. Therefore, these assays are mostly of the endpoint type. More 
recently, new substrates for H2O2 have been introduced, for example certain fluorescent 
resorufin derivatives32,33 and the so-called Amplex Red34 which enable kinetic assays since 
they can be applied at near-neutral pH. In a recent study35, a lanthanide complex of the 
product formed from pHPA through POx-assisted oxidation was used for H2O2 detection 
using time resolution. Conceivably, it may be applied to glucose assay. In addition to 
fluorescent assays, numerous chemiluminescent methods (known for particularly low limits 
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of detection) have been reported36. It should be kept in mind, though, that most glucose assays 
are applied to sample solutions where analyte concentrations are not extremely low. 
A new direct and time-resolved ("gated") glucose detection scheme is presented here 
based on the detection of H2O2 produced by the GOx reaction using a europium-derived 
fluorescent probe37. It has the specific features that make lanthanide-based probes so popular 
and versatile38,39, and offers the first H2O2-based time-resolved fluorescence assay that does 
not require the presence of a peroxidase. In addition, it works best at neutral pH. 
3.2. Results and Discussion 
3.2.1. Assay Principle 
The fluorescent probe EuTc has been reported37 to be useful for determination of 
H2O2. The absorption and emission spectra of the probe in absence and presence, respectively, 
of glucose and glucose oxidase (GOx) are shown in Fig. 3.1. The unique properties of the 
complex with between H2O2 and EuTc (referred to as EuTc-HP) include an absorption 
maximum around 400 nm, an ~210-nm Stokes' shift, and a line-like fluorescence emission 
peaking at 616 nm. The principle of the glucose assay is based on the oxidation of glucose by 
GOx (see Eq. 3.1 and 3.2) and the subsequent conversion of the weakly fluorescent EuTc into 
the strongly fluorescent EuTc-HP by H2O2 according to following equilibrium: 
 
glucose + O2   –—(GOx)→   D-gluconolactone  +  H2O2 
H2O2 + EuTc (weak fluorescence) →  EuTc-HP (strong fluorescence) 
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The increase in fluorescence due to the production of H2O2 is smaller than would be 
expected. It is assumed that this is due to the presence of traces of catalase in the GOx as 
indicated by the provider who gives a catalase activity of ≤ 10 units per mg GOx. Catalase 
interferes anyway, and the assay reported here requires the absence of any interfering levels of 
catalase in order to function well. In fact, the EuTc-HP system can be used for the 
quantitation of catalase40. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Absorbance spectra (left) and emission spectra (right) of the EuTc/GOx system in 
absence and presence, respectively, of glucose. A: 1 mL of EuTc stock solution plus 200 µL of a 
54.1 U/mL glucose oxidase stock solution and 1790 µL of MOPS buffer. B: 10 µL of a 27.7 mmol L-1 
glucose solution added to A and incubated at room temperature for 30 min with occasional shaking. 
Please note that the ratio is only 4 times due to the glucose added. 
The kinetic response of the GOx/EuTc system to rising concentrations of glucose (at 
a constant activity of GOx) is shown in Figure. 3.2. With higher glucose concentrations, and 
therefore increasing production of hydrogen peroxide, fluorescence intensity increases 
strongly due to formation of EuTc-HP. Hence, the glucose concentration can be detected 
directly without further addition of peroxidase or another substrate. Endpoint determination is 
the preferred format in this case, and the drift can be easily subtracted in a microplate assay. 
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Figure 3.2. Kinetic response over 30 min of the EuTc/GOx system to increasing concentrations 
of glucose. 100 µL of EuTc 0.2 mmol L-1 stock solution, 20 µL of a 54.1 U/mL glucose oxidase stock 
solution, and MOPS buffer made up to a total volume of 200 µL, with glucose concentrations of 0.0, 
13.86, 27.72, 69.3, 138.6, 277, 693 µmol L-1 from A to G. 
The response of the fluorescent probe is due to the formation of EuTc-HP, rather 
than to other effects. Glucose alone has no significant effect on the fluorescence of EuTc and 
of EuTc-HP. In addition, deactivated GOx does not cause any changes over time. While 
active GOx in the concentrations used here has no effect on EuTc, it did slowly decrease the 
fluorescence of EuTc-HP (Fig. 3.2, line A). The drift in the baseline of EuTc and GOx in the 
absence of glucose is likely due to temperature effects or interaction of EuTc with the GOx 
protein. 
3.2.2. Fluorescence Intensity-based Assays 
Glucose is present in serum and in many other samples in rather high (>3 mmol L-1) 
concentrations. Such levels of glucose are preferably determined in a kinetic way, typically 
over 5 min. The assay has been adapted to these conditions as described in the Experimental 
Part so to match glucose concentrations between 0.5 and 10.0 mmol L-1. As can be seen in 
Figure 3.3, the kinetic response over 5 min is quite linear. 
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Figure 3.3. Kinetic response over 5 min of the glucose oxidase/EuTc system to increasing 
concentrations of glucose in the mmol L-1 range. Experimental conditions: 100 µL of EuTc 0.2 
mmol L-1 stock solution, 2 µL of a 55.0 U/mL GOx stock solution, and MOPS buffer made up to a 
total volume of 200 µL, with glucose conc. (from A to G) of 0, 0.66, 1.32, 2.63, 5.27, 10.5 mmol L-1. 
In order to quantify even low concentrations of glucose, an endpoint method is 
developed, including a 30-min incubation time at 30 °C, and by increasing the activity of the 
GOx employed and the concentration of EuTc. A stable signal is reached after a >20-min 
incubation at 30 °C as can be seen from Figure 3.2. The temperature chosen is in the optimal 
range for GOx41. 
The effect of oxygen as one of reactants was also studied. Although oxygen acts as a 
weak quencher37 of the fluorescence of EuTc-HP (its intensity decreases by 10% on going 
from nitrogen-saturated solutions to air-purged solutions), the oxygen supply for the glucose 
detection is more than adequate as proven by the results obtained with and without shaking, 
respectively. Under these two conditions, the time trace of the detection is virtually identical. 
The optimal pH range of detection is 6.6 – 7.2 which is the optimal range for both EuTc-HP 
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and GOx37,41. Outside this range, the fluorescence intensity drops rapidly, being only 15% of 
the maximum at pH 8.0, and 8% at pH 6.0. 
The interferences of common cations and anions were studied and no significant 
effects were found for alkali ions and chloride in up to 100 mmol L-1 concentrations, and also 
for various other cations and anions at up to 100 µmol L-1 levels. Known interferents for the 
GOx-POx system, such as ascorbic acid, uric acid, and bilirubin, also have no significant 
effect as shown in Table 3.1, probably because no peroxidase is involved and the transient 
concentration of free H2O2 is never as high as in some other assays. It is likely, though, that in 
case of higher H2O2 concentration there will be interference by ascorbic acid, uric acid, 
bilirubin, and glutathione. They have a <10% effect if present in concentrations of, 
respectively, 40, 132.5, 8.6, and 19.8 µmol L-1 in the wells (corresponding to 160, 530, 35, 
and 79 µmol L-1, respectively, in the 50 µL samples added). Phosphate and citrate ions inhibit 
or interfere at even micromolar concentrations. Free Cu2+ ion interferes with EuTc-HP and 
inhibits GOx. 
 
Table 3.1. Effect of common interferents for GOx-POx system on EuTc glucose assay.a) 
Interferent Concentrations (µmol L
-1) in the 
wells (in the stock solution) Relative fluorescence intensity (%) 
ascorbic acid 15.0   (100) 37.5   (250) 
99.5 
97.4 
uric acid 15.0   (100) 30.0   (200) 
97.4 
95.2 
bilirubin 3.0   (20) 6.0   (40) 
100.1 
94.5 
a) Experimental details: test solution: 100 µL of the EuTc stock solution, 20 µL of GOx (54.1 U/mL), 50 µL of 
glucose solution (2.77 mmol L-1), 30 µL of interference substance (stock concen. as shown above in brackets), 
and MOPS buffer to make up to a total volume of 200 µL; 30 min incubation at 30 °C ; the relative intensity 
refers to that of a solution without interferent. 
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A calibration plot was established for the direct determination of glucose as 
described in the protocol with the Ascent reader. The linear range is from 2.7 to 100 µmol L-1, 
the linear regression equation being described by y = –167.1 + 392.5x (r = 0.99, n = 3 for each 
point). The limit of detection (S/N = 3) is 2.7 µmol L-1. The kinetic deterination of millimolar 
concentrations of glucose within 5 min results in a linear regression equation described by y = 
0.91 + 0.25 * x (r = 0.98, n = 3 for each point). 
3.2.3. Time-resolved (gated) Fluorescence Assay 
Lanthanide complexes usually display long decay times, typically between 0.01 and 
10 ms. This feature has made them quite popular for time-resolved fluorescent detection, 
mostly in context with immunoassays, gene assays, and high-throughput screening. The time-
resolved ("gated") detection scheme can effectively eliminate background fluorescence, such 
as the intrinsic short-lived fluorescence of proteins and microplates. EuTc and EuTc-HP can 
also be applied to this scheme since their average decay times (30 and 60 µs, respectively) are 
significantly different. In addition, the fluorescence intensity of EuTc-HP is significantly 
higher than that of EuTc37. In view of this, time-resolved (gated) detection becomes possible 
by selecting a suitable lag time and integration time as indicated in Fig. 3.4. 
Both the lag time and integration time were optimized in the gated assay. The 
optimal lag time range for the detection is around 50 – 125 µs as shown in Fig. 3.5. We use a 
60 µs delay since it gives a good signal-noise ratio, but other lag times may be used as well. 
The integration time has no significant effect on going from 40 µs to 300 µs. However, the 
EuTc fluorescence cannot be gated out completely despite the fact that EuTc-HP has a main 
lifetime twice that of EuTc. This is due to (a) the fact that EuTc with its main component of 
~30 µs is still present to some extent after 60 µs, and (b) a small but slowly (>~60) decaying 
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component of EuTc which cannot be eliminated by gating. On the other side, gated detection 
with a lag time of 60 µs is more than adequate to overcome the background fluorescence of 
the samples and microplates which usually have ns decay times. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Fluorescence decay profiles of EuTc and EuTc-HP, respectively, and a schematic of 
the time-resolved (gated) assay employed here. By picking a lag time of 60 µs most of the 
background fluorescence of EuTc is suppressed, while that of EuTc-HP is detected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Optimization of the lag time of the time-resolved glucose assay. The solution in the 
well is composed of 100 µL of EuTc stock solution, 20 µL of the 54.1 U/mL GOx, 50 µL of a 2.77 
mmol L-1 glucose, and 30 µL of MOPS. The blank consists of 200 µL of MOPS. Its fluorescence (F0 
(blank)) is used for background correction. Fluorescence was measured after 30 min at 30 °C. 
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A calibration plot for the gated glucose assay (30 min; described in the recommended 
protocol) is given in Fig. 3.6. The dynamic range is from 2.2 to 100 µmol L-1, the linear 
regression equation being described by y = 0.122 + 0.164x (r = 0.99, n = 3 for each point). 
The calculated limit of detection (S/N = 3) is 2.2 µmol L-1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Calibration of glucose in the time-resolved (gated) determination. Glucose solutions of 
different concentrations, 100 µL of EuTc (0.2 mmol L-1) stock solution, 20 µL of 54.1 U/mL glucose 
oxidase stock solution, and MOPS solution made up to a total volume of 200 µL. Data were acquired 
after 30 min at 30 °C. The lag time of the time-resolved assay was set to 60 µs, and the integration 
time to 40 µs. The fluorescence intensities (F) obtained with glucose solutions are corrected for F0 (the 
fluorescence intensity of a blank containing no glucose). 
3.2.4. Comparison 
A lot of methods have been described so far for glucose determination. Among those, 
direct H2O2 based optical detection methods based on the use of GOx are still most sensitive 
and most frequently used as summarized in Table 3.2. The GOx-POx based assay is widely 
used. However, this coupled enzymatic scheme requires a chromogenic or fluorogenic 
reaction by POx for the optical signal production, e.g. with Trinder’s reagent or Amplex Red. 
This potentially introduces new interferences, such as by ascorbic acid23, uric acid, and other 
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electron-donating substances, and thereby increases the complexity of the detection. Direct 
H2O2 detection without POx can overcome these disadvantages.  
Few methods are available for the direct detection of glucose via H2O2 without POx. 
Metal complexes, such as those of vanadium, titanium and ferric ions, have been used since 
they form colored adducts with H2O2. However, these methods mainly exploit changes in 
absorbance or reflectance. Table 3.2 also lists the optimal pH values. It should be noted, 
however, that recommended pH values of <6 cannot easily be adjusted to in certain samples. 
Recently, a direct glucose assay was presented that is based on the deacetylation of 
weakly fluorescent acetylresorufin. The fluorescence produced by resorufin is used for the 
determination of glucose, and common POx interferents remain inert. However, the over-
oxidation of fluorescent resorufin or resazurin substrate itself may lead to quenching of the 
fluorescence and therefore compromise the determination. This is also true for the resorufin 
analogs such as Amplex red or resazurin. 
Compared to other assays (Table 3.2), the method introduced here appears to be the 
first one that is applicable to gated fluorometry (a) at pH 7, (b) without addition of an enzyme 
substrate for POx, (c) without the need for addition of POx, and (d) without the need for UV 
excitation which is known to cause a strong fluorescent background from either the sample or 
cuvettes and microplates. Moreover, over-oxidation (as in case of resorufin or resazurin) has 
not been observed (Fig. 3.6). In fact, the fluorescence of the system at glucose concentrations 
as high as 700 µM (after a 30 min incubation at 30 °C) is constant over time after having 
reached the endpoint. Finally, the assay reported here is applicable to both kinetic and 
endpoint determination. Glucose in the concentration range occurring in blood plasma (3 – 20 
mM) is preferably determined by kinetic 1-point detection. 
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Table 3.2. Overview on H2O2-based optical assays for glucose along with recommended pH values (or pH ranges) a) 
Reagent(s) Ref. LOD (µmol L-1) 
Linear range 
(µ mol L-1) 
pH 
range Remarks 
via vanadium complex 27 300 300 – 2400  absorbance measured at 582 nm; end point detection only; ascorbate and uric acid do not interfere 
via titanium complex 28,29,30 0.5 0.5 – 500 6.3 – 8.0 absorbance measured at 450 nm; end point detection only; ascorbate and uric acid probably do not interfere 
via ferric iron complex 31 10 30 – 200 5.5 absorbance measured at 575 nm; end point detection only; ascorbate and uric acid probably do not interfere 
Trinder/POx 21,22,23,42 11.1 11.1 - 55.5 >7.5 absorbance measured at 750 nm; end point detection; ascorbate, uric acid and bilirubin probably interfere 
homovanillic acid 
/POx 
24,25,26 1.7 1.7 – 17 8.5 
fluorescence measured at exc/em wavelengths of 315/425 nm; UV 
fluorescence background from biomatter may interfere; kinetic 
detection and end point detection possible; ascorbate, uric acid and 
bilirubin probably interfere 
Amplex Red /POx 34 1 or 3 ~ 3 – 40 7.4 
fluorescence measured at exc/em wavelengths of 530-560/~590 nm; 
kinetic detection and end point detection possible; overoxidation 
observed at >500 µM glucose; asborbate, uric acid and bilirubin 
probably interfere 
acetylresorufin 32, 33 200 200 – 2000 7.4 
fluorescence determined at exc/em at 568/582 nm; kinetic detection 
and end point detection possible; ascorbate, uric acid and bilirubin 
do not interfere; over-oxidation of resorufin to resazurin possible 
EuTc this method 2.2 2.2 - 100 6.5 – 7.5 
fluorescence measured at exc/em 405/620 nm; capable of both 
kinetic and end point detection; time-resolved assay possible; 
ascorbate, uric acid and bilirubin do not interfere 
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In conclusion, the glucose assay reported here has several novel and useful features 
including the good accessibility of the reagent, high sensitivity, large Stokes’ shift, stability 
towards oxygen; and a working pH of ~7. These make it an attractive alternative for glucose-
related biomedical research and in diagnosis, not the least because this kind of assay is based 
on a widely applicable probe so that other assays may be performed with similar or even 
identical instrumentation.  
3.2.5. Analysis of Other Substrates of Oxidases 
The EuTc fluorescent probe has also been studied for analysis of galactose, sarcosine 
and lactate, but without success. As show in Figure 3.7, only glucose oxidase gives the 
anticipated increase due to the production of H2O2. This might partially due to the nature of 
the enzymes, because (1) the specific activity of GOx is usually much higher than that of the 
other enzymes, and consequently much more enzyme proteins are in presence, which may 
interfere and quench the fluorescence of EuTc-HP; (2) the stability of the other enzymes is not 
as good as GOx; and (3) the nature of EuTc and EuTc-HP itself might also be the reason as 
will discussed latter in the thesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Time-trace of the other oxidases. 
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3.3. Experimental (Please see Chapter 7 for the reagents and instruments) 
Glucose Assay Protocol 
For determination of glucose in milimolar range (as found in plasma), the assay was 
optimized for measurement within 5 min. Place, in each well of a thermostatted (30 °C) 96-
well microplate, 100 µL of the EuTc solution, 2 µL of GOx (55.0 U/mL), and MOPS buffer to 
make up the total volume to 200 µL. The samples (95 µL) containing glucose between 0.5 
and 10 mmol L-1 were added simultaneously, and the plates were read on the GENios+ reader 
in intervals of shaking over 5 min, with a lag time of 60 µs and an integration time of 40 µs. 
Control experiments were conducted by replacing glucose samples with buffer, to give blank 
signal denoted as F0. The blank was subtracted from the fluorescence with glucose for the 
detection. All microplate experiments were done in triplicate. 
In order to obtain very low limits of detection, a 30 min incubation at 30 °C and a 
higher enzyme activity was employed. In each well of a thermostatted (30 °C) 96-well 
microplate were placed 100 µL of the EuTc solution, 20 µL of GOx solution (54.1 U/mL), 
and MOPS buffer to make up the total volume to 200 µL. The samples (50 µL) containing 
glucose in concentrations between 5 and 100 µmol L-1 were added thereafter, and the wells 
were read on the GENios+ reader (under intervals of shaking) as programmed, with a lag time 
of 60 µs and an integration time of 40 µs. Control experiments were conducted by adding 
buffer in place of glucose samples to give a signal denoted as F0. The blank was subtracted 
from the fluorescence signal obtained with glucose solutions.  
For the steady-state intensity measurement, the same plate composition was used, 
and measured on the Fluoroskan Ascent reader. 
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Chapter 4. Fluorescence Imaging of the Activity of Glucose Oxidase 
4.1. Introduction 
Glucose oxidase (GOx, EC 1.1.3.4) is a flavoenzyme that catalyzes specifically the 
oxidation of glucose into gluconate and hydrogen peroxide (Eq. 4.1).1It is one of the most 
widely used enzymes for its availability and its stability. As a representative of oxidases, it 
has been studied in solution as well as in the immobilization on solid surfaces,2 or in 
encapsulation in the microsphere3 for the application in biosensors,4 industrial bioreactors,5 
and bio-fuel cells.6 Apo-glucose oxidase has also been utilized in studies for “nanowiring”7 of 
the electron transfer. GOx has been applied not only to the electrochemical and optical 
determination of glucose,8 but also in GOx-labelled enzyme amplification analysis for 
immunoassays.9 GOx based enzyme immunoassays have been used for the quantitation and 
screening of e.g. steroids, drugs, environmental pollutants, special peptides.10 Recently, it also 
has been applied to microchip or microarray technologies for the development of protein 
chips for proteomics.11 
 
Numerous methods have been developed for the determination of GOx. A set of 
assays have emerged based on determination of oxygen,12 pH,13 or H2O2,14,15. However, 
methods based on the measurement of H2O2 produced by GOx are of particular interest 
because H2O2 does not form a background but is only produced during enzymatic reaction. 
Since H2O2 cannot be easily visualized, it is usually converted into a colored or fluorescent 
product using peroxidase (POx). 
Glucose + O2  →GOx,  →hydrolysis  D-Gluconate + H2O2 + H+   …….Eq. 4.1 
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In recent years, fluorescent imaging technologies have attracted substantial attention 
because of the multitude of information on both the spatial and temporal characterization of 
the target analyte.16,17 Confocal,18 multi-photon excitation,19 near-field20 and lifetime-based 
imaging21,22 technologies have been developed for different applications. Unfortunately, 
known methods for imaging GOx are restricted mainly to scanning electrochemical 
imaging23, and scanning chemiluminescence imaging24. This is largely due to the fact that 
almost all fluorescence imaging methods for GOx are in need for a second enzyme (POx) in 
order to visualize the H2O2 produced by the GOx catalyzed reaction. There have been reports 
on H2O2 based imaging using dihydrorhodamine 123,25 homovanilic acid26, scopoletin27, 
dichlorodihydrofluorescein diacetate,28 or others29, all in conjugation with POx as the second 
chromogenic or fluorogenic enzyme.30 
Based on the previous reports on the europium tetracycline (EuTc) fluorescent 
probe,31,32 here is presented a direct detection scheme for GOx at neutral pH and without the 
need for a second enzyme, and a fluorescent imaging to visualize the GOx activity. Due to the 
long fluorescence decay time of the probe, intensity-based, time-resolved and lifetime-based 
imaging for quantitative detection of the activity of GOx are also explored. 
4.2. Results and Discussion 
4.2.1. Principle and Characterization of the Detection System 
The direct assay for GOx activity via H2O2 is based on the response of EuTc to 
enzymatically produced H2O2 to give the much stronger fluorescent EuTc complex with H2O2 
(EuTc-HP), as following: 
EuTc (weakly fluorescent, τ ~30 µs) + H2O2 → EuTc-HP (highly fluorescent, τ ~60 µs) 
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The kinetic response of the glucose/EuTc system with rising activities of GOx is 
shown in Figure 4.1. With higher activities of GOx, and therefore increasing production of 
hydrogen peroxide, fluorescence increases due to the formation of the strongly fluorescent 
europium-tetracycline-hydrogen peroxide (EuTc-HP) system. Glucose and GOx themselves 
have no significant effect on the fluorescent probe, while ascorbate, uric acid, phosphate and 
citrate interfere.32 Because of the differences in the average decay times of EuTc (~30 µs) and 
EuTc-HP (~60 µs),31,32 the time-resolved and decay time based determination and imaging 
become possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 1. Kinetic response of the glucose/EuTc system to increasing activities of GOx. 
100 µL of a 0.2 mmol L-1 EuTc stock solution, 15 µL of a 277.2 mmol L-1 glucose solution, and 
MOPS buffer made up to a total volume of 200 µL. Glucose oxidase activities (from A to G): 0.0, 
0.27, 0.54, 1.4, 2.7, 5.4 and 13.5 mUnit/mL respectively. 
4.2.2. Imaging Setup and Analytical Schemes 
The setup of the imaging system is an adapted version of an earlier system33,34 that 
takes into account the larger Stokes shift (~210 nm), and the µs decay times of the probes. 
Cut-off optical filters and a common ns pulse generator are adequate for the optimal imaging 
of GOx. 
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The four imaging schemes shown in Figure 4.2 have been tested for their suitablity 
for quantitative imaging of GOx activity. Their features are summarized in Table 4.1. In 
conventional fluorescence intensity imaging (FII) 29 one detection window is opened while 
excitation is on. In contrast to this often applied method, in time-resolved imaging (TRI)35,36 
the detection window is opened after the excitation pulse. TRI imaging technology is most 
useful to eliminate (by gating) the autofluorescence of samples and plates with their 
nanosecond decay times. These two are mainly intensity-based detection schemes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Schematic principles of four imaging schemes. Timelines of Window 1 and Window 2 
of the four imaging schemes are indicated in Table 1. 
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Table 4.1. Figures of merit for the four imaging schemes studied in this work. 
  FII∗ TRI PDR RLD 
ti 0 0 0 0 Excitation tt 50 50 50 50 
ti 0 80 0 80 Window 1 (W1) tt 50 130 50 130 
ti 0 0 100 180 Window 2 (W2) tt 0 0 150 300 
ti as the initiating time, tt as the terminating time, all times in µs. ∗: FII: Fluorescent intensity imaging; TRI: Time resolved imaging; PDR: Phase delay 
rationing imaging; RLD: Rapid lifetime determination imaging. 
 
Luminescence decay time-based detection can also be exploited for imaging 
purposes and have certain advantages since they are independent of light source and detector 
fluctuations, the concentration of the fluorophore, and light scatter. The commonly used on-
the-fly detection techniques for lifetime are utilized here with a two-window detection and 
ratiometric quantification as shown  in Eq. 4.2: 
         …………………………Eq. 4.2 
Phase delay rationing imaging (PDR)34,37 is based on the acquisition of two windows, 
one in the excitation phase and one in the phase after excitation. The ratio of the two windows 
can be used for the quantification of the activities of GOx. Rapid lifetime determination 
imaging (RLD),38,39 in contrast, is based on the acquisition of two windows after excitation, 
the ratio of intensities of the two windows enabling a rapid determination of lifetime. 
The resulting intensity-based and lifetime-based GOx images are displayed in Figure 
4.3. They indicate that the fluorescent probe EuTc is applicable to all four schemes. The 
intensity-based (FII, Fig. 4.3 A and TRI, Fig. 4.3 B) images are clearly affected by the 
intensity fluctuations of the excitation light source and by scattering as indicated by the 
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inhomogeneity in the wells. In contrast, the lifetime-based images assays (PDR and RLD, see 
Figures 4.3 C and 4.3 D) in contrast, reveal good homogeneity due to their independence of 
intensity variation of the excitation light, the quantity of the fluorophore present in the wells, 
and of scattered light. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Four different images of the activity of glucose oxidase after respective data 
processing. A: Fluorescent intensity imaging (FII); B: Time-resolved imaging (TRI); C: Phase delay 
imaging (PDR); D: Rapid lifetime imaging (RLD). Experimental parameters are specified in Table 1, 
the respective data processing in the experimental part. Composition of the wells in the images (from 
left to right in duplicate) is as following: Decreasing GOx activities (from 135, 54.1, 27.1, 13.5, 5.4, 
2.7, 1.35, 0.54, 0.27, 0.14, 0.05, and 0 (blank) mUnit/mL respectively), 100 µL of a 0.2 mmol L-1 
EuTc, 15 µL of a 277.2 mmol L-1 glucose, and the total volume made up to 200 µL with MOPS. 
Previous studies have shown that ratiometric methods of PDR and  RLD are suitable 
for on-the-fly detection of the fluorescence lifetime.40 For example, the RLD method is most 
adequate for a mono-exponential decay, however with the possibility of applying it to multi-
exponential decays.41 For multi-exponentially decaying systems like EuTc and EuTc-HP, the 
precision in the determination of the average lifetimes, however, is known to greatly depend 
on the selection of the detection windows.42 For the same windows, the ratios of the two 
windows change monotonically with the concentration of H2O2 formed by the glucose 
oxidase reaction as indicated by our experiments above. 
A: FII B: TRI 
C: PDI D: RLI 
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4.2.3. Quantitative Aspects of GOx Imaging 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Rapid lifetime determination imaging of the activity of glucose oxidase. 
 A: Normalized ratio of the two images (false color). B: grey scale image of the activity of glucose 
oxidase; C: The calibration curve of the activity of glucose oxidase. Experiments were performed in 
triplicate (rows). The composition of the wells in the images is as: from 1 to 12, with glucose oxidase 
activities from 0 (blank), 135, 54.1, 27.1, 13.5, 5.4, 2.7, 1.35, 0.54, 0.27, 0.14, and 0.05 mUnit/mL 
respectively, 100 µL of a 0.2 mmol L-1 EuTc solution, 15 µL of a 277.2 mmol L-1 glucose solution, 
and the total volume made up to 200 µL with MOPS buffer. 
The scheme was optimized with respect to the concentration of glucose and the 
concentration of EuTc. The optimal response (i.e. the largest change in fluorescence intensity) 
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was obtained when 20 mmol L-1 glucose and 100 µmol L-1 EuTc in the 200 µL well were 
used. The steady-state endpoint method is used since the reaction reaches the endpoint after a 
30-min incubation, as can be seen from Figure 2. The different activities of GOx result in the 
different intensities of EuTc-HP. Although kinetic detection also is possible, it is less favored 
because it is much more complicated than endpoint imaging. 
The rapid lifetime determination (RLD) scheme was further exploited for the 
quantitative imaging of the activity of GOx. The normalized ratio of the two images is shown 
in Figure 4.4 A. Figure 4.4 B illustrates the ratios in grey scale images after basic calculation, 
Figure 4.4 C the response of average ratio of the specific wells in the images to the presence 
of different activities of GOx. Imaging is linear from 0.32 to 2.7 mUnit/mL, with a detection 
limit of about 0.32 mUnit/mL (1.7 ng mL-1). 
 
4.2.4. Time-resolved Determination of GOx Using a Microplate Reader 
Gating may also be applied to the determination of the activity of GOx via a 
microplate reader. The gated detection with a lag time of 60 µs and a integration time of 40 µs 
is by far adequate to overcome the background fluorescence of the samples and plates which 
usually have nanosecond lifetimes. The microplate reader assay resulted in a linear range 
from 0.32 to 14 mUnit/mL, with a limit of detection (S/N = 3) 0.32 mUnit/mL. The 
microplate assay, compared to the imaging, usually has a broader dynamic range and smaller 
standard deviations. 
4.2.5. Comparison 
The method presented here uses a single fluorescent probe and - to the best of our 
knowledge – is the first assay of GOx compatible with both time resolution (gating) and 
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lifetime-based imaging. No lifetime-based oxidase detection or imaging via H2O2 has been 
reported so far. However, an oxygen-based assay of GOx has been reported43,44 that is based 
on the measurement of the phase shift of an oxygen-sensitive fluorescent probe. 
On the other hand, lanthanide-based fluorescence has been widely used in time-
resolved (gated) assays and in imaging 35,36 due to decay times of the probes which are in the 
order of µs to ms. However, lanthanides are mainly used in the form of covalent labels, 
sometimes incorporated in microspheres. In the scheme reported here, dissolved EuTc is used 
as an H2O2-sensitive probe. There is no need for reagents other than glucose and EuTc. 
Imaging of GOx (and possibly other oxidases such as uricase), offers the possibility 
of the construction of multi-enzyme or multi-substrate arrays45. The capability spatial 
discrimination also makes imaging applicable to assess enzyme activity in immobilization 
studies,46 such as for testing the quality of glucose biosensors based on GOx.  
The methods reported here for imaging GOx activity is possible by both intensity 
based and lifetime based methods due to the unique features of the fluorescent probe EuTc 
and its complex formed with H2O2 (EuTc-HP). These include easy accessibility, high 
sensitivity, large Stokes’ shift (~210 nm), a line-like fluorescence at 616 nm; an average 
decay time of ~30 and 60 µs respectively; compatibility with LED lightsources; stability 
towards oxygen; and a working pH of ~7.  In conclusion, the scheme presented here enables a 
straightforward method for imaging of GOx activities in microplates that, conceivably, may 
be extended to enzyme amplification immunoassays, high-throughput screening, 
immobilization studies and microarray technologies. 
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4.3. Experimental (Please see Chapter 7 for the reagents and instruments) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Setup of the imaging system. A: fast gateable CCD-camera (SensiMod); B: optical 
emission filter (KV 550); C: light-guiding adapter, consisting of 96 optical fibers (Ø = 3 mm); D: 96 
well microtiterplate (black one with transparent bottom); E: optical excitation filter (BG 12); F: 
pulsable LED array with 96 UV light emitting diodes (λmax = 405 nm). 
Imaging Device. The device used in this study has been previously reported33,34 and 
was used with minor modifications. As shown schematically in Figure 4.5, it is composed of a 
fast gateable CCD-camera (SensiMod; from PCO, Kelheim, Germany; www.pco.de), a 
pulsable LED array with 96 UV light emitting diodes (λmax 405 nm, Roithner Laser Technik, 
Vienna; www.roithner-laser.com/), a pulse generator (Scientific Instruments DG 535, 
Sunnyvale, California, www.srsys.com, not shown in Figure 1), an optical emission filter (KV 
550; Schott, Mainz, Germany; www.schott.com), and an optical excitation filter (BG 12; 
Schott), with a light-guiding adapter consisting of 96 optical fibers (Ø = 3 mm) for matching 
the focus of the CCD camera. A personal computer was used for controlling and visualization 
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of the experiments as programmed in Interactive Data Language (IDL, Research Systems, 
Boulder, CO, USA; www.rsinc.com). 
The manipulation and calculation of images, such as the rotation and crop of the 
images, the subtraction of the dark image (blank, without illumination) from the fluorescent 
image respectively, the ratio of the images and filtration of the background noise, were done 
by a self-developed program based on Matlab (6.1, Mathwork, Natick, MA, USA; 
www.mathwork.com). The images of the ratio from lifetime-based detection were inverted to 
their negatives for a more facile comparison of different methods. 
Imaging of the Activity of GOx. To each well of a 96-well microtiter plate with 
transparent bottom were added 100 µL of the EuTc standard solution, 15 µL of a 277 mmol L-
1 glucose solution, and enough MOPS buffer to make up the total volume to 200 µL. The 
samples (50 µL) containing GOx with an activity between 1.2 and 5.6 mUnit/mL were added 
simultaneously. The images of the plates were taken after a 30-min incubation at 30 °C. Blank 
values (F0) were obtained by adding buffer in place of GOx. In the time-resolved (gated) non-
imaging determination using micro titer plates with a fluorescence reader, a lag time of 60 µs 
and an integration time of 40 µs were employed32. 
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Chapter 5. Determination of the Activity of Catalase 
5.1. Introduction 
Catalase (hydrogen peroxide:hydrogen peroxide oxidoreductase, EC 1.11.1.6; here 
referred to as CAT), is capable of decomposing hydrogen peroxide (H2O2) without producing 
free radicals1. It has long been recognized as a defense for the oxidative stress2 and plays an 
important role in the compartmentalization of H2O2 in biological systems3. Therefore, it has 
been widely studied for its role in physiological and pathological processes4 such as the 
detoxification of H2O2, the modulation of H2O2 as a messenger, the brain catalase response 
for alcohol, and in relation to acute or chronic hepatitis. It has also found applications in 
environmental monitoring as an early marker of environmental organic pollution5, in the food 
industry for detection of bacteria6, and even for the detection of life on the moon7. In addition, 
catalase is often added to biosensor systems in order to prevent any adverse effects of H2O2 
which is formed during the enzymatic activity of oxidases including glucose oxidase. 
Catalase is relatively unique compared to other members of the peroxidase family 
since it displays both catalase activity (EC 1.11.1.6; see reaction Eq. 5.1) and peroxidase 
activity (EC 1.11.1.7; Eq. 5.2). Typical substrates of peroxidase activity (SH2 in Eq. 5.2) 
include ethanol, methanol, formate, nitrite, phenol, and others. 
 
 2 H2O2  →CAT   2 H2O + O2  (catalase activity)   ……………Eq. 5.1 
 H2O2 +  SH2  →CAT    H2O + S (peroxidase activity)   …………Eq. 5.2 
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Numerous methods have been developed for measuring the activity of CAT. The 
decomposition of H2O2 can be monitored spectrophotometrically at 240 nm8,9, or via 
chemiluminescence10,11. One may also detect the production of oxygen (reaction 1) by either 
an oxygen electrode12 or a low-flow gas meter7. In order to circumvent spectrophotometry at 
240 nm (which is prone to interferences by other absorbers), the competitive consumption of 
H2O2 by catalase and by peroxidase, respectively, can be monitored using chromogenic or 
fluorogenic substrates13. However, spectrophotometric detection at 240 nm still is the most 
widely used method since it has the advantage of being kinetic, and because other methods 
usually involve two or more steps or reagents. Unfortunately, the UV photometric method is 
not easily applicable to complex samples displaying strong intrinsic absorption at 240 nm. 
Recently, the weakly fluorescent Eu3+-tetracycline complex (EuTc) has been 
introduced  as a promising new fluorescent probe for detection of H2O2. The latter acts as a 
fluorescence-enhancing ligand14,15. As little as 1.8 µmol L-1 concentrations of H2O2 are 
detectable at near neutral pH. In fact, the effect has been used previously to improve the limits 
of detection in the determination of the drug tetracycline16 but appears to have an even larger 
potential in biosciences, since almost all oxidases produce H2O2 during their activity.  
Here, a novel europium(III) ion derived fluorescent probe is presented for qualitative 
and quantitative determination of CAT, along with a new one-step fluorescent assay of CAT. 
The determination is based on the finding that the H2O2 in the fluorescent system EuTc-HP 
can be decomposed by CAT, thus leading to a large decrease in its fluorescence due to 
formation of the much less fluorescent EuTc. 
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5.2. Results and Discussion 
In light of our previous studies14,15, we found that the fluorescent system formed 
between H2O2 and EuTc (referred to as EuTc-HP) is reversibly decomposed by the enzyme 
catalase (CAT). Hence, H2O2 cannot have oxidized one of the components of the EuTc 
complex, but rather must be present in a form that makes it acceptable to this highly specific 
enzyme. Further studies revealed that the EuTc-HP system represents a novel fluorescent 
probe for CAT that can be used for the direct assay of CAT. 
5.2.1. Characterization and Optimization of the Assay 
The kinetic response of the EuTc-HP complex system to various activities of CAT is 
shown in Figure 5.1. The fluorescence of the EuTc-HP system decreases faster with 
increasing activity of CAT, the slope thus reflecting the actual activity of CAT.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 5.1. Kinetics of the decomposition of the EuTc-HP system by catalase. The activities of 
catalase are (from top) 0 (= blank), 1.02, 1.53, 3.07, 6.13, 30.7, 51.1, 102.2, and 204.4 unit/mL, 
respectively. The conc. of EuTc was 52 µmol L-1 (with respect to Tc), that of H2O2 was 0.4 mmol L-1). 
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Figure 5.2 Optimization of the concentration of H2O2 for the detection of catalase. Curve A: 
Fluorescence intensity of EuTc-HP without adding catalase. Curve B: difference between blank and 
fluorescence intensity after 10 min in presence of 10.2 unit/mL of catalase and 0.32 mmol L-1 EuTc 
(with respect to Tc). 
The effect of the concentration of H2O2 on the assay can be seen in Figure 5.2. 
Firstly, an increase in concentration largely enhances the fluorescence of the system (left axis 
of Figure 5.2). However, higher H2O2 concentrations result in a smaller change of the 
fluorescence on addition of CAT, as seen on the right axis in Figure 5.2. This is due to the fact 
that the most sensitive range of EuTc to H2O2 concentration is at less than 0.6 mmol L-1 
(Figure 5.3). Although higher H2O2 concentrations resulted in higher fluorescence, the 
decrease in fluorescence due to the consumption of H2O2 was smaller. Consequently, smaller 
changes are observed at high H2O2 levels. In any case, the assay only works in the range 
where consumption of H2O2 makes a difference to the total amount of EuTc-HP. Furthermore, 
the activity of the CAT is proportional to the concentration of H2O213, 19, 20. The balance of the 
three aspects led us to use a 0.4 mmol L-1 concentration of H2O2 in the well, and this 
concentration was applied in the recommended procedure. It resulted not only in high 
fluorescence, but also in relative large signal changes, however without significant 
deactivation of CAT. 
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Figure. 5.3. Effect of the concentration of hydrogen peroxide on the fluorescence intensity of 
EuTc-HP; EuTc concentrations (with respect to Tc) ranging from 8 (bottom), 
 to 16, 40, 64, 80 and 96 (top) µmol L-1, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 5.4. Optimization of the concentration of EuTc for the detection of catalase. Curve C: 
Fluorescence intensity of EuTc-HP (formed from EuTc and H2O2) without adding catalase (= blank). 
Curve D: Difference between blank and fluorescence intensity after 10 min 
 in presence of 1.0 mmol L-1 of hydrogen peroxide and 10.22 unit/mL of catalase. 
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The concentration of the probe EuTc-HP was also optimized. As shown in Figure 
5.4, the optimal concentration is at around 50 µmol L-1. Although an increase in the 
concentration resulted in an increase in fluorescence intensity, the relative decrease as a result 
of addition of CAT reached a maximum at a concentration of 50 µmol L-1, but decreased on 
further increasing it. As shown in Figure 5.3, the point of inflection shifts with the 
concentration of EuTc. 
A calibration plot for the CAT kinetic assay as described in the recommended 
protocol is given in Figure 5.5A. The linear range of the catalytic activity of catalase is from 1 
to 10 unit/mL, the linear regression equation being described y = 4.540 + 2.758x (r = 0.99, P 
< 0.0001). The limit of detection (LOD; S/N = 3) is 1.0 unit CAT per mL. The limit of 
detection was further improved by incubation over 30 min and at 37 °C. As shown in Figure 
5.5 B, the LOD is 46 milliunit/mL, with a linear range between 46 and 400 milliunit/mL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 5.5. Calibration curves for catalase. Graph 6A: calibration curve for catalase with a specific 
acitivity between 1 and 10 unit/mL by kinetic detection without incubation. Graph 6B: calibration 
curve for catalase with a specific activity between 49 and 400 milliunit/mL of catalase by one-point 
detection after 30 min incubation at 37 °C. The solution was 50 µmol L-1 in EuTc (with respect to Tc), 
40 mmol L-1 in H2O2; and the total volume (250 µL) was made up with MOPS buffer. 
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Kinetic determination which exploits the time-dependent differences in fluorescence 
intensity is considered to be advantageous, especially for fast CAT-assisted reactions. When 
scanning the wells of a microplate, there will be a time delay between the single wells. In case 
of performing a one-point measurement after typically 30 min, the effect of the time delay of 
the readings of the single wells will not be significant any more. The improved LOD of the 
30-min assay can be further explained by Figure 5.3: a longer incubation time, an increased 
activity of CAT along with a higher temperature will cause distinctly more H2O2 to be 
consumed in the steepest range of the EuTc-HP fluorescence. Consequently, much less CAT 
can be quantified. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 5.6. Monomer structure of catalase (tetramer). (His 74 in green color) 
5.2.2. Inhibition and Denaturation of Catalase 
3-Amino-1,2,4-triazole (3-AT) is a specific CAT inhibitor, which in presence of 
H2O2, inhibits CAT by reacting with the functional groups (His 74) in the active center of 
CAT (Figure 5.6). The inhibition effect of 3-AT on CAT as monitored via the new probe is 
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shown in Figure 5.7. 3-AT acts as a specific inhibitor of CAT only in the presence of H2O2. 
As can be seen from Figure 5.7, 3-AT inhibits the reaction, while 3-AT has little effect on the 
fluorescence of the EuTc-HP system. If denatured CAT is used, no difference with the blank 
was observed in fluorescence, while active CAT had a large effect. The inhibition and 
denaturation experiments show that it the decrease observed in fluorescence is due to the 
enzymatic consumption of H2O2 by CAT, and not by other effects such as interactions 
between EuTc and CAT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 5.7. Specific inhibition of catalase by 3-amino-1,2,4-triazole (3-AT). A: blank; B: blank 
plus 3-AT; C: plus catalase but without 3-AT; D to G: plus catalase and 3-AT in concentrations of 2.2, 
6.7, 9.0 and 11.2 mmol L-1, respectively. The following concentrations were employed: EuTc: 52 
µmol L-1(with respect to Tc); H2O2 1 mmol L-1, CAT 10.2 unit/mL). 
 
5.2.3. Interferents 
The possible interference of common anions and cations on the detection was also 
explored. The fluorescence of the EuTc-HP complex system is not affected by alkali, alkali 
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nitrate in up to ~100 mmol L-1 concentrations. Fluoride acts as a weak quencher if present in a 
concentration higher than 0.1 mmol L-1. However, phosphate and copper(II) ions are strong 
quenchers of the system. Furthermore, the fluorescence of the EuTc-HP system is weakly 
quenched by molecular oxygen. An 11% decrease in fluorescence intensity was observed on 
going from nitrogen-saturated solutions to air-saturated solutions.  
Among the conceivable organic interferents that were tested, ascorbate, uric acid, 
bilirubin and glutathione interfere weakly in displaying a slight quenching effect on the EuTc-
HP system if present in concentrations of >6.4, 40.0, 6.9, and 15.8 µmol L-1 respectively in 
the wells. Fortunately, these species usually are present in constant concentrations in catalase 
assays. Alternatively, calibration may be performed in presence of these interferents. 
5.2.4. Discussion 
Describe here is what appears to be the first direct fluorescent probe for catalase. 
From the findings presented so far we conclude that the EuTc-HP probe is a ternary complex 
system, in which H2O2, on addition to EuTc, replaces water molecule(s) ligated to Eu3+ to 
form a new ligand, without however undergoing any significant redox reactions. Binding 
would be weak as anticipated, and in order to create measurable quantities of the EuTc-HP 
complex, a substantial fraction of "free" H2O2 is needed to drive the reaction to the right side. 
  EuTc + H2O2  <===> EuTc-HP  …………………………Eq. 5.3 
Hence, Eq. 5.3 is better formulated as Eq. 5.4: 
  EuTc + n H2O2  <===> EuTc-HP  + (n – 1) H2O2  ………..Eq. 5.4 
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In order to schematically indicate that a fraction of H2O2 is present in "free" form. If 
"free" H2O2 is decomposed by catalase, equilibrium (4) is shifted to the left side, i. e. to the 
less fluorescent EuTc complex. Alternatively, one may assume that the H2O2 bound to EuTc 
in the EuTc-HP complex (Eq. 5.3 and Eq. 5.4) is directly decomposed by CAT (for a 
schematic description of both situations see Figure 5.8). We do, however, not favor this 
assumption because (a) H2O2 is present in excess, (b) CAT is highly specific for H2O2, and (c) 
the active site of CAT hardly accessible for the relatively large EuTc-HP complex. 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8. Schematic representation of the two conceivable mechanisms 
 of the decomposition of the EuTc-HP system by catalase. 
Previous studies have revealed that the effect observed on addition of H2O2 is largest 
if the molar ratio of Eu:Tc is 3:1. We find the same here for the reverse reaction (caused by 
CAT). The unusual stoichiometry has therefore been the subject of further studies. A Job plot 
(fluorescence intensity vs. ration of Eu:Tc, see Figure 6.9) gave the same molar ratio (3:1). 
Attempts failed to obtain crystals for performing an x-ray structural analysis. Circular 
dichroism spectra and UV spectra (Figure 2.1) are hardly different for EuTc and EuTc-HP, 
respectively. Thus, the structure of the system is not elucidated yet. The existence of 2:1 
complexes such as the Cu2Tc complex21 is noted here, along with the fact that the number of 
binding sites of Tc is strongly pH dependent22. 
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Due to the fast reaction rates of CAT13, the reaction mechanism does not imply the 
formation of a detectable enzyme-substrate complex, as is the case in most enzyme-catalyzed 
reactions. Consequently, the activity of CAT depends on the concentration of H2O2 being 
present initially. Moreover, H2O2 in concentrations above 0.1 mol L-1 even deactivates CAT. 
An optimized H2O2 concentration therefore has to be a trade-off between the two features of 
this unique catalytic system for the optimal sensitive detection. Unlike in other enzyme 
detection schemes, the concentration of the substrate (H2O2) has to be specified when 
specifying activity. Unfortunately, some researchers have proposed other definitions of 
activity, but without clearly specifying the working concentrations of H2O2, a fact that makes 
comparison of data from different laboratories rather difficult. 
Numerous optical assays for catalase have been developed. Table 5.1 summarizes 
some features of merits for commonly used assays for catalase. In the recommended 
photometric assay8, the H2O2 concentration (as determined by photometry at 240 nm) 
typically drops from 10.2 to 9.3 mmol L-1. Despite its disadvantages, this method is still 
widely used, for example when studying catalase overexpression, probably because it is the 
only direct kinetic method and requires a single substrate only (H2O2). 
The Trinder reagents23, like other chromogenic phenols, aromatic amines or 
aminophenazones, are applied in combination with peroxidase for detection of catalase. In a 
recent report13, 3,5-dichloro-2-hydroxy-benzenesulfonate is used as a chromogenic substrate 
(see Table 5.1). Unfortunately, any involvement of peroxidase in the detection procedure will 
change the H2O2 concentration in the system and thus will affect the activity of CAT. 
The Amplex method24 allows for an ultrasensitive fluorescent determination of CAT. 
A two-step procedure is recommended to avoid the interference by peroxidase. However, this 
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two-step endpoint detection limits its applicability to continuous kinetic assays. 
Chemiluminescence detection of catalase10,11 has also been developed, especially for the case 
of extremely low concentration of H2O2. Again, kinetic continuous detection is rather 
difficult. 
Compared to the above methods for CAT detection, the one described here is directly 
kinetic (or one-point after prolonged incubation), works at a clearly defined H2O2 
concentration and at neutral pH, and does not require the addition of other substrates or 
enzymes. The assay can be performed using microplates and is fully compatible with plate 
readers. Additional features of this probe include a Stokes shift of 210 nm, a line-like 
emission centered at 616 nm (where background luminescence from biological materials and 
microplates is weak), a decay time in the µs range, and excellent compatibility with the 405-
nm diode laser. Such features provide distinct advantages over the UV method and two-step 
or two-reagent methods. 
In conclusion, a novel fluorescent probe for the catalase and a one-step kinetic assay 
for the catalase are introduced. The probe enables an easy, direct, automation-compatible, 
relative inexpensive alternative to existing methods for detection and quantitation of CAT. 
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Table 5.1. Overview on commonly used assays for catalase and hydrogen peroxide (H2O2), 
 and respective features of merit including limits of detection (LODs).  
Method Ref. LOD for H2O2 
LOD for catalase 
(unit/mL) 
H2O2 concentration 
employed Remarks 
UV 8,9 - ~ 10 9.2 – 10.3 mmol L-1 photometry at 240 nm; kinetic 
Amplex Red 24 50 nmol L-1 0.050 10-20 µmol L-1 fluorescence; two steps of  30 min each 
Trinder 13 - ~ 0.1 unspecified photometry at 505 nm; color inhibition 
Chemiluminescence 10,11 - ~ 0.2 20 - 40 µmol L-1 in-situ generation of H2O2; kinetic 
EuTc-HP this method 1.8 µmol L-1 0.046 400 µmol L-1 kinetic; gated measurements possible 
Data for activity units are based on the Sigma definition:  
(One unit decomposes 1 µmole of of H2O2 per minute at pH 7.0 at 25 °C, while the H2O2 concentration falls from 10.3 to 9.2 mmol L-1). 
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5.3. Experimental (Please see Chapter 7 for the reagents and instruments) 
Recommended CAT Assay Protocol 
Place, in each well of a thermostatted (30 °C) 96-well microplate, 65 µL of 0.2 mmol 
L-1 EuTc stock solution, 20 µL of a 5 mmol L-1 solution of H2O2 in water, and MOPS buffer 
to make up the volume to a total of 250 µL. After 10 min, the samples (50 µL) containing 
catalase with an activity between 5 and 100 unit/mL were added simultaneously, and the 
plates were read under intervals of shaking as programmed. Control experiments were 
conducted without adding catalase under similar conditions. 
The kinetic change of the fluorescence was used for the quantification of the activity 
of catalase. The kinetic changes in fluorescence between 0 and 10 min (F0 and F respectively) 
were used for calibration versus the activity determined by UV spectrophotometry at 240 nm. 
For detection of extremely low activities, a one-point detection (i. e., a single measurement 
after a fixed period of time) was used with F0 as the blank without CAT and F as the 
fluorescence with CAT after a 30-min incubation at 37 °C. 
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Figure 6.1 Scheme of the principle of GOx-ELISA. 
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6.1. Application of GOx-based ELISA 
Enzyme-linked immunosorbent assays (ELISA)1,2,3,4 have been widely utilized as 
one of the basic immunoassays in clinical research5,6,7 for the diagnostic and understanding of 
diseases, in biochemical research for signal transducation8 and other cell regulatory 
processes9, and in pharmaceutical industry for the discovery and screening of potential 
therapeutic drugs10,11,12. The enzymatic amplification nature has made it one of the most 
sensitive methods for the analysis of the biologically important molecules. Peroxidase (POx), 
alkline phosphatase, and galactosidase have been mostly used as enzyme labels for the 
fluorescent or chemiluminescent measurements13,14,15,16, while catalase and glucose oxidase 
(GOx) are only sometimes used due to the lack of direct assays and their available assays 
always have to be coupled with POx. Time-resolved fluorescent immunoassays, such as 
dissociation enhanced lanthanide fluoroimmunoassay (DELFIA)17,18,19, have more advantages 
than the usual fluorescent assays because of their ability to eliminate the background 
fluorescence of proteins. 
Here, a GOx-based ELISA assay for IgG is presented. Its principle is indicated in 
Figure 6.1, as an application of the EuTc fluorescent probe for H2O2. The GOx ELISA is 
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based on the direct determination of H2O2 produced by the GOx catalyzed reaction. H2O2 
binds with EuTc to form EuTc-HP which is highly fluorescent and has a µs lifetime for the 
potential time-resolved measurements. 
Two schemes of ELISA have been tested as shown in Figure 6.2 (see section 6.5.1 
for protocol). Sandwich ELISA needs two different antibodies to recognize the target antigens 
(IgG here) and offers amplification functions, while direct ELISA only need the enzyme–
labeled antibody for amplification purposes. Sandwich ELISA usually is more complicated 
than direct ELISA but with better sensitivity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 Schemes of sandwich (capture) GOx-ELISA and Direct GOx-ELISA. 
The kinetic studies on the GOx-ELISA in sandwich format are shown in Figure 6.3. 
The fluorescence changes as the formation of EuTc-HP through the GOx-labeled anti-IgG, 
which is immobilized through the immunobinding to the analyte IgG. It catalyzes the 
oxidation of glucose, thereby forming H2O2. The amount of GOx conjugated anti-IgG can be 
determined by the fluorescence intensity of EuTc-HP system, and therefore the amount of IgG 
in sample. Curve (E) is a time trace over 50 min for blank, which is handled exactly the same 
as other wells, except adding no target molecular IgG. (A) to (C) are curves of kinetic process 
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with increasing concentration of IgG, and consequently increasing amount of GOx-anti-IgG. 
With increasing GOx-anti-IgG, from (A) to (C), the slope of curve, as well as the intensity, is 
increasing, which can be used to analyze IgG. The similar time response is also observed for 
the direct GOx-ELISA.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 Time trace of the formation of EuTc-HP from EuTc and hydrogen peroxide produced 
by GOx-Anti-IgG conjugate. (A)-(C) trace after incubation of 250, 150, 50, 15 ng/ml of IgG, 
respectively; (E) blank. 
The calibration curves (see 6.5.1 for protocol) of IgG by the end-point of 
fluorescence are shown in Figure 6.4. It shows that (1) for sandwich GOx-ELISA, its limit of 
detection ( S/N = 3) is 3 ng/ml, and the linear range is between 10 – 250 ng/ml, y = 0.12 + 
0.010x, r = 0.99; (2) for direct GOx-ELISA, the limit of detection ( S/N = 3) is 20 ng/ml, and 
the linear range is between 50 - 500 ng/ml, y = 0.051 + 0.005x, r = 0.99; (3) the sandwich 
GOx-ELISA with the fluorescent EuTc probe is more sensitive than the direct GOx-ELISA; 
(4) the sandwich GOx-ELISA can fit for the requirements of regular clinical assay and direct 
GOx-ELISA can be available for the determination of high concentrations of IgG. 
 
 
20 30 40 50
4
5
6
7
E
D
C
B
A
flu
or
es
ce
nt
 in
te
ns
ity
tim e (m in)
Chapter 6. Further Applications and Structure of EuTc-HP 
 89 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 Calibration plot for IgG by GOx-Anti-IgG in the well of a microplate versus the 
increase in fluorescence intensity (F-F0) over 50 min 
 
GOx has been used before for ELISA20,21, but much less than POx or others, partially 
because most of the GOx assays need POx as well. Compared with earlier GOx-ELISA, the 
method offered here can be performed without the need of POx and offers the potential of 
time-resolved application, especially in the light of recent development of protein chip22 array 
technology. As the most studied enzyme for immobilization, GOx shows much more 
advantges than POx in chip-based ELISA for the proteomics23, if a direct measurement 
without the need of coupling POx is presented as seeing here. 
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6.2. The Catalase/Glucose Oxidase System 
Coupled enzyme systems have long been recognized as a superb tool for studying 
complicated enzymes and as a way of quantifying enzyme substrates. Most of the multi-
enzyme systems are cascade systems such as those for creatinine, cholesterol, and choline. 
Some of them are steady-state system, where the consumption and the production of the 
substrate reach a steady state. Examples include the catalase-glucose oxidase system, the 
Krebs cycle, and in biological organelles, such as the peroxisome24. The steady-state enzyme 
system usually requires the reversibe probes rather than irreversible ones to minitor the kinetic 
changes, if possible in real time. Based on the reversible interaction of EuTc with H2O2, a 
catalase–glucose oxidase system is studied by the EuTc/EuTc-HP fluorescent system as a 
platform for screening of antioxidative agents, especially those inhibit the oxidases, or those 
promote catalase. 
6.2.1. The Catalase/Glucose Oxidase System as a Platform for Screening 
While there are numerous reports on screening platforms for kinases and 
phosphatases25,26, seldomly any screening platforms for oxidative processes have been 
studied. The reversible fluorescent EuTc/EuTc-HP system may also be used in studies on 
peroxisomes, in particular its steady state that is reached by normal chronic response and by 
emergency acute response, as was shown by Mueller24 et al. for peroxisome proliferation 
using a flow injection chemiluminescent system for H2O2 detection.  
As mentioned earlier in this thesis, the fluorescence intensity of EuTc-HP is much 
higher than that of EuTc, and the highly fluorescent EuTc-HP system (formed from EuTc and 
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H2O2 at neutral pH and at room temperature) is decomposed to the less fluorescent EuTc 
system. As shown in Figure 6.5, EuTc and EuTc-HP form a reversible system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5 Reversible EuTc/EuTc-HP system 
The reversibility is confirmed by the following findings: (1) Catalase, which is 
highly specific for H2O2, can decompose H2O2 in the EuTc-HP system and turn it back into 
EuTc if H2O2 is fully consumed. (2) The catalase-specific inhibitor 3-AT27, retards the 
reaction, and increasing quantities of 3-AT result in a distinctly decreased activity; (3) The 
formation of EuTc-HP and its decomposition are nonoxidative processes in view of the 
minute differences in the absorbance and circular dichroism (CD) spectra between the two 
species as in Figure 2.1. In fact, the CD spectra are rather similar, and no significant new peak 
is observed that would point to reaction products with quite different chemical structure from 
tetracycline. (4) The reversibility of the fluorescent H2O2 system is further demonstrated by a 
coupled reaction involving glucose, glucose oxidase (GOx) and catalase (catalase) as shown 
in Fig. 6.6(A) (see section 6.5.2 for experimetal details). 
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Figure 6.6 The coupled CAT-GOx system as a platform for screening. (A) the kinetic response of 
the EuTc-HP and the coupled CAT-GOx system. (B) lower part: photographic images of the different 
steps (a to g) as in experimental section 6.5.2; upper part: the intensity pattern of the red fluorescence 
of the respective images in the lower part. 
The formation of the coupled GOx-CAT enzymatic system is shown in 
Figure 6.6 A. When H2O2 is added to a solution containing EuTc and glucose in MOPS 
buffer, a large increase in fluorescence is observed due to the formation of EuTc-HP. 
Subsequently, catalase is added upon which a continuous decrease in fluorescence intensity 
can be seen (due to catalytic decomposition of H2O2 by catalase). On further addition of GOx 
(which produces more H2O2), the system turns into a coupled GOx-CAT enzymatic system, 
which is known for its production of constant H2O2 in steady state for at least hours28,29. 
The advantages of the coupled system composed of catalase and glucose oxidase 
(GOx) are best presented by acting as a model for a screening platform for studying activation 
and inhibition. As can be seen in Figure 6.6 A, the steady state of the system responds to 
inhibitors of catalase (3-AT) and GOx (Hg2+, a potent GOx inhibitor30). Fluorescence 
increases as 3-AT is added, and decreases on addition of Hg2+, thus forming a new system for 
antioxidative drug screening. Since screening is often performed in the imaging mode, the 
digital pictures at different stages of the experiment that reflect the time course of the red 
fluorescence intensity (Figure 6.6 B) are also taken for the quantitative imaging processing. 
 
Time (s)
0 2000 4000 6000 8000 10000
Fl
uo
re
sc
en
ce
 (a
.u
.)
1
2
3
4
H2O2
Catalase
Glucose
Oxidase
3-AT
Hg2+
3-AT
Catalase
A B 
a b c d e f g
R
e
d
 i
n
te
n
s
it
y
 (
a
.U
.)
6 0
8 0
1 0 0
1 2 0
1 4 0
1 6 0
1 8 0
2 0 0
2 2 0
Chapter 6. Further Applications and Structure of EuTc-HP 
 93 
The dynamic changes can also be manifested by an animation of the series of the digital 
photos or video. 
6.2.2. Detection of Catalase Independent of H2O2 
As a alternative to the method of Chapter 5, the activity of catalase may also be 
determined by the catalase-GOx coupled system, with the additional feature that it will be 
independent of the actual H2O2 concentration in the media. This may help to overcome 
current limitations when comparing catalase activities which are known to be dependent on 
substrate concentration. Since in the coupled system described above the final (steady state) 
concentration of H2O2 is proportitional to kGOx/kcatalase28, and by keeping the concentrations of 
glucose and dioxygen at constant levels, the response of the system is a direct parameter of 
the activity of catalase that is independent of the H2O2 concentration. A respective calibration 
plot is given in Figure 6.7. This approach is much simpler and versatile than the method given 
in a recent report24. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7. Determination of catalase (CAT) activity using EuTc-HP. Calibration graph for a 
determination based on the catalase-GOx steady-state equilibrium. 
CAT (U/ml)
0 5 10 15 20 25
1/
F s
te
ad
y-
st
at
e
0,020
0,022
0,024
0,026
0,028
0,030
0,032
0,034
0,036
0,038
Chapter 6. Further Applications and Structure of EuTc-HP 
 94 
Glucose 
6.3. Construction of Microplate Arrays and Sensors 
Starting from the earlier single analyte (point) detection, the most recently 
development of the bioanalysis is the use of two dimensional arrays for high-throughput 
screening and multi-analyte measurements. Besides different microarrays, such as DNA 
chips31, fluorescence-based fiber optic arrays32, there have been new advances using 
microplates as the matrix for array construction33 for the multiple analyte determination. 
Initiated by the site-specifically immobilized enzyme arrays34, a study on the 
construction of arrays and sensors is presented here that is based on the fluorescent EuTc and 
EuTc-HP probes. The scheme has been integrated into microplate (MTP) technology (in order 
to form disposable sensor arrays and for the use of fluorescence imaging which allows the 
reading of all parameters simultaneously). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8. Fluorescencce images of microplate array and sensor for glucose and GOx. 
The microplate sensors and arrays are constructed by the immobilization of 
biotinylated glucose oxidase on streptavidin-coated microplate through the biotin-avidin 
interactions. The fluorescence images are shown in Figure 6.8. Figure 6.8 (A) is for the 
determination of glucose with the same concentration of the biotinylated glucose oxidase, 
GOx 
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with increasing concentration of glucose specified in Table 6.1, and in triplicate as shown in 
column a, b, c. Figure 6.8 (B) is for the measurement of immobilized GOx with the same 
concentration of glucose, with increasing concentrations of GOx for immobilization specified 
in Table 6.2, and also in triplicate as column a, b, c. The RLD lifetime-based imaging method 
was applied as well, with the same composition of the samples in the wells. 
Table 6.1 Composition of the samples for glucose sensor (array). 
 1 2 3 4 5 6 7 8 
GOx-Biotin 0 0 20 20 20 20 20 20 
EuTc 0 100 100 100 100 100 100 100 
Glucose 0 0 0 1 2 5 8 10 
MOPS 200 100 80 79 78 75 72 70 
Total 200 200 200 200 200 200 200 200 
GOx-Biotin(mU) 0 0 1370 1370 1370 1370 1370 1370 
Glucose(mM) 0 0 0 1.39 2.77 6.93 11.01 13.86 
 
Table 6.2 Composition of the samples for glucose oxidase (array). 
 1 2 3 4 5 6 7 8 
GOx-Biotin 0 20 50 20 50 20 50 85 
EuTc 100 100 100 100 100 100 100 100 
Glucose 15 15 15 15 15 15 15 15 
MOPS 85 85 85 85 85 85 85 85 
Total 200 200 200 200 200 200 200 200 
Glucose(mM) 20.81 20.81 20.81 20.81 20.81 20.81 20.81 20.81 
GOx-Biotin(mU) 0 0.108 0.271 1.082 2.706 10.82 27.06 46.00 
 
As anticipated, the fluorescence intensity imaging is not as homogeneous as the RLD 
fluorescence imaging. Despite the variation between the triplicates, they still show the same 
trend as a change of glucose concentrations or the immobilized GOx on microplates. These 
preliminary results of the imagies confirm the feasibility of the construction of microplate-
based sensors and arrays for the determination of glucose and of GOx immobilized on the 
microplates. The purpose is for multienzyme arrays for the assay of multi-substrates 
simultaneously on a single shot of detection with microplates. 
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6.4. Composition of the Fluorescent Probes 
Lanthanide(III) ion complexes have received much attention during the last two 
decades for their interesting photophysical properties and their usages as candidates for a 
number of applications. Ln(III) ions, due to their unique luminescence properties, such as 
long lumine-scence decay time and narrow emission bands, can form highly luminescent 
complexes with specific ligands. In such complexes due to strong ligand absorption and 
efficient energy transfer from the ligand to the metal ion (termed as `antenna effect'), strong 
Ln(III) lumine-scence is observed, overcoming the very small absorption coefficients of the 
lanthanide(III) ions. There are mainly two classes of such specific ligands35. The first, e.g. 
cryptands, calixarenes, β-diketones, macrocyclic ligands, carboxylic acid derivatives, and etc, 
involves the system that are effectively coordinatively saturated by octa- or nonadentate 
ligands and forming kinetically stable binary complexes (mostly 1:1 complexes). This kind of 
ligands usually is not affected by the environment and consequently is mainly applied as 
labels for bioassays. The second class, such as tetracycline, however, usually relates to 
complexes that are not coordinatively saturated. There are always water molecules involved in 
the inner field of the coordination field, resulting in smaller quantum yields, shorter lifetimes. 
This kind of ligands in most cases has lower overall stability and is prone to form ternary 
complexes, sometimes even multi-nuclear compleses, rather than the 1:1 binary complexes. 
These com-plexes are relavtively less developed than the first ones. However these com-
plexes can be applied as fluorescent probes rather than fluorescent labels, which are sensitive 
to certain analytes in the aqueous media, such as the EuTc-HP complex presented here. 
In fact, there are quite a few reports about the properties and structure of the 
europium tetracycline complexes, such as earlier reports by Schulman36, et al. on tetracycline 
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detection, and Ci, et al.37 on nucleic acid detection. Compared to the earlier research, the 
EuTc-HP system here is a ternary complex sensitive to H2O2, with a perculiar metal-to-ligand 
ratio of 3:1. In this section, the peculiar composition of the probe will be further studied. 
6.4.1. Stoichiometry and Structure 
There is an unusual molar ratio (3 to 1) of Eu to Tc as a sensitive probe for H2O2. 
The case only happens for H2O2 binding with the EuTc complex. As shown in Figure 6.9 A, 
Job’s plot has been applied for the determination of the molar ratio in the EuTc-HP complex. 
The fluorescence intensity reaches the highest when the molar ratio of Eu to Tc is 3:1 in the 
EuTc complex, in different H2O2 concentrations. Hence, EuTc is in 3:1 molar ratio as applied 
in different applications throughout this study. This is quite peculiar, since there have been 
plenty of reports36,38 on the EuTc complex itself. Earlier researches have suggested a 1:2 
molar ratio of the complex and later the ratio was corrected to be 1:1 through different 
methods of characterization. It is also confirmed by our own experiment that, with no H2O2 
presented, the molar ratio in EuTc complex is 1:1 when fluorescence is the highest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.9 Job’s plot for EuTc-HP. 
 A. Eu3+ to Tc molar ratio in different conc. of H2O2, Ctotal=CEu+CTc; 
 B: Tc to H2O2 molar ratio in different conc. of Eu3+, Ctotal=CH2O2+CTc. 
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The exact structure of EuTc, especially EuTc-HP therefore is of great interest. 
Although a variety of techniques have been used to study the complexation behavior of 
tetracycline and various derivatives, the results obtained have led to partly contrary 
assignments of the chelation sites. Depending on the chosen experimental conditions, i.e. 
nature of the solvent, pH as well as ligand-metal molar ratio, tetracyclines can form 
complexes exhibiting a 2:1, 1:1, or 1:2 ligand:metal stoichiometry39,40. 
For example, Mg2+ was reported39 to form a 2:1 metal to ligand complex when in 
excess, binding to N4-O3 at the A-ring site and O12-O11 at the BCD ring (Figure 6.10). This 
can be partially supported by the observed shift of the long wavelength band attributed to 
binding of Mg2+ to Tc at N4-O3 and the observed shoulder on the long wavelength absorption 
band and the observed pronounced increase in the integrated fluorescence intensity attributed 
to the other Mg2+ chelates to O12-O11. Another example is the oxovanadium(IV) ions 
complexes with Tc40, which form a 2:1 metal–ligand binuclear complex with tetracycline at 
pH 6. The isolated binuclear complex has been characterized with the proposed structure 
shown in Figure 6.10. Therefore it is reasonable to suggest that tetracycline can also form a 
2:1 metal–ligand binuclear complex like Mg2+ and oxovanadium(IV) ions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10 Proposed molecular structures of the 2Mg2+-Tc and 2VO2+–TC complexes. 
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On the other hand, pH is a significant factor on tetracycline, since that at different 
pH, Tc can be in different form (even different tautomers) of protonation. The possible 
binding sites of metal ions depend on the nature of the solvent and the pH value, since 
chelation occurs predominantly at basic sites, and metal ions (as well as Eu3+) prefer O and N 
donors. Tetracycline exhibits three macroscopic acidity constants, the assignments of which 
have been widely accepted, despite some controversy depending on the solvents and presence 
of metal ions. In aqueous environment the first deprotonation (pK1 ~ 3-4) occurs at OH3. The 
second pK value is attributed to OH12 (pK2 ~ 7.3-8.1), and the third one to the protonated 
nitrogen of the (CH3)2- group (pK3 ~ 8.8-9.8)40,41,42, as shown in Figure 6.11.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.11 Tetracycline structure and assignment of pKas. 
As calculated from the pKa values of tetracycline (Figure 6.12), the main forms at pH 
6.9 which has the highest fluorescence for EuTc-HP, are H2Tc- and H3Tc0. In the presence of 
Eu3+, tetracycline, and H2O2, the pH of the system is determined by the tetracycline 
protonation, europium hydrolysis and the extremely weak protonation of H2O2, if there is no 
other reactions involved. Although the optimal pH of 6.9 might be reasonable from the pH 
additional effects of the presence of the several species, these evidence still can not explain 
the 3:1 stoichiometry of EuTc-HP, and further clarification is still needed. 
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First suggested as a mechanism step in the catalytical hydrolysis of RNA43, the 
following equilibrium was suggested for the reaction between Eu3+ and H2O2: 
)3,2(2)(2 3322
3 =+−−−→+ ++++ nHnEuOOEuOHnEu n  
This equilibrium was further tested with pH variation as simulated in Figure 6.12 as 
the line of Eu-(O-O)n-Eu. At pH > 6.5, a fairly stable Eu3+-(O-O)n-Eu3+(n=3) system is 
formed for the specific accelerated hydrolysis of RNA43. 
As a summary of all above arguments, the following mechanism steps are suggested 
for the explanation of the peculiar molar ratio of Eu to Tc in the EuTc-HP complex: 
 
 
 
 
 
 
 
 
 
 
EuTcTcEu K→++ 13 …………………………………………………Eq. 6.1 
TcEuEuTcEu K 2
23 →++ …………………………………………….Eq. 6.2 
)3,2(2)(2 322
3 =+−−−→+ ++ nHnEuOOEuOHnEu nK …….Eq. 6.3 
EuOOEuEuTcEuOOEuEuTc n
K
n −−−−→−−−+ )()( 4 ………...Eq. 6.4 
Figure 6.12 pH-dependent form of tetracycline. 
Black and red lines as the pH-dependent percentage of H3Tc0 and H2Tc-1. Blue line as the pH-dependent 
fluorescence of EuTc-HP. Cyan line as the pH-dependent formation of Eu-(O-O)3-Eu44 
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The possible structure of EuTc-HP is proposed as shown in Figure 6.13. The 
proposed structure and mechanism up to now offer the only reasonable explanation for the 3:1 
metal–ligand EuTc-HP complex. The previous considerations on (1) the oxidation of 
tetracycline; (2) formation of free radicals; (3) formation of peroxo europium ions; and (4) 
formation of H2O2 adduct44, were either ruled out (such as tetracycline oxidation, or formation 
of free radicals), or could not offer a reasonable explanation for the stoichiometry. 
Furthermore, the proposed structure also results in the enhanced fluorescence and prolonged 
fluorescence lifetime same as the other possibilities mentioned above. The formation of the 
Eu complex in the O11-O12 site (or the BCD ring), just as that binding for Mg2+; the 
replacement of possible inner field water molecules of the Eu binding to Tc by peroxide 
linkage, and the possible electron withdrawing effect of the far end Eu3+ facilitating the 
energy transfer from Tc to Eu, all might contribute to the fluorescence characterization of 
EuTc-HP. In addition, since the K3 in the mechanism step of Eq. 6.3 is in the range of 
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Figure 6.13 Proposed structure of EuTc-HP in the form of EuTc-HP 
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 3.3x10-31 M2 (n=3) or 1.4x10-23 M (n=2)43, the formation of the a fairly stable Eu3+-(O-O)n-
Eu3+ is most likely reversible. It also partially gives an explanation of the multi-component 
luminescence decay of EuTc and EuTc-HP. 
It should be noted that this structure is not confirmed yet, partially due to the 
instability of the peroxide complex, especially in solid form, which has hindered the effort of 
the further structural characterization. There are also small conflicts, such as the molar ratio of 
Tc to H2O2 as obtained from Job’s plot is 1:2 (Figure 6.9 B), rather than 1:3, so that n is more 
likely to be 2 in Eu3+-(O-O)n-Eu3+ while the Eu3+-(O-O)2-Eu3+ complex has a higher pH to 
obtain stable complex, such as pH 7.5, although this might be explainable through further 
calculation of optimal pH in EuTc-HP. 
6.4.2. Combinatorial Approach for Discovery of New Lanthanide Probes 
The uncertainty of the structure of EuTc-HP results in the combinatorial approach for 
the further development of new lanthanide–tetracycline fluorescent probes. The basic idea 
behind the approach is the variation of the tetracycline structure for an even better probe for 
H2O2. In the experiments, the 3:1 stoichiometry and a pH of 6.9 are also applied. 
The preliminary results (structures fluorescence intensities and quantum yields) are 
summarized in Figure 6.14, Figure 6.15 and Table 6.3. 
Analysis of the luminescence spectra and quantum yield leads us to the following 
conclusions: 1) oxidation in X4 position does not greatly affect the quantum yield of the 
fluorescent probe, as shown in the case of oxytetracycline as a decomposition product of Tc. 
This also further rules out the tetracycline oxidation mechanism. 2) The spatial hindrance in 
X5 position is not important for the generation of the fluorescence, such as with 
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rolitetracycline hydrochloride. This offers the possibility for the covalent immobilization of 
tetracycline for the construction of sensors based on EuTc complexes. 3) The hydroxyl group 
in X3 is quite important. Without it, the quantum yields are normally low as in the cases of 
minocycline hydrochloride and minocycline hydrochloride. 4) The spatial hindrance in X2 
position has some effects on the fluorescence generation as compared the chlortetracycline 
hydrochloride and the demeclocycline hydrochloride. 5) In X1 position, the electron donating 
and withdrawing groups have similar minimal effect, but the spatial hindrance is harmful for 
the fluorescence. 
 
 
 
 
 
 
 
 
 
Figure 6.14 The structures of tetracycline and its analogs. 
Table 6.3. The structures of tetracycline and its analogs 
Name (Tx)  X1 X2 X3 X4 X5 Y Quantum yield (EuTx-HP, %) 
Tetracycline 
 hydrochloride A H Me OH H H Cl 4.0 
Chlortetracycline 
hydrochloride B Cl Me OH H H Cl 1.2 
Rolitetracycline 
hydrochloride C H Me OH H N  
Cl 4.3 
Oxytetracycline 
hydrochloride D H Me OH OH H Cl 5.7 
Demeclocycline 
hydrochloride E Cl H OH H H Cl 2.6 
Doxycycline 
 hydrochloride F H Me H OH H Cl 1.5 
Minocycline 
 hydrochloride G -N(CH3)2 H H H H Cl 0.5 
Meclocycline 
sulfosalicylate salt H Cl =CH2 OH H 
Sulfo-
salicylate 0.8 
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Figure 6.14 Fluorescence of EuTx and EuTx-HP as specified in Table 6.3. 
A-H as in Table 6.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.15 pH optimum(A) and optimal molar ratios of Eu to Tx (B) of all EuTx-HP 
A-H as in Table 6.3 
 
The pH optimum and optimal molar ratios of all EuTx-HP is shown in Figure 6.15. 
These knowledge provides the basis for the further molecule design for the better 
lanthanide probes for H2O2. 
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6.5. Experimental (Please see Chapter 7 for the reagents and instruments) 
6.5.1. Protocol of GOx-labeled Immunoassay 
The scheme of sandwich GOx-ELISA is shown in Figure 6.2. The affinity reaction is 
proceeded as: (1) add 200 µl rabbit anti-bovine-IgG at a concentration of 5 µg/ml in PBS into 
each well of a polystyrene U-bottom microplate, incubate at 37 °C for 1 hour. Alternatively, 
incubate at 4 °C overnight; (2) block remaining binding sites in each well by incubating with 
220 µl of 1% BSA, incubate at 37 °C for 30 min; (3) add 200µl diluted sample antigen bovine 
IgG in PBS to each well, incubate at 37 °C for 1 hour; (4) add 200 µl of monoclonal anti-
bovine IgG biotin conjugate at 1:1000 in each well, incubate at 37 °C for 1 hour; (5) add 200 
µl of 10 µg/ml streptavidin in PBS to each well of microplate, incubate at room temperature 
for 30 min, then add 200 µl of 3 U/mL GOx-biotin in PBS to each well of the microplate, 
incubate at room temperature for 30 min. Between two coatings, rinse 3 times by PBS. Last 
rinse with MOPS buffer before adding the EuTc probe. PBS was used for the incubation steps 
and later was washed out at last step of washing. 
The fluorescence detection is as following: 250 µl of of EuTc and glucose mixture 
(as prepared by mixing 5.0 ml of EuTc stock solution, 5.0 ml of 27 mmol/L glucose solution, 
and MOPS buffer to make up volume to 25 ml. The solution should be prepared fresh every 
times.) is added to each well of samples. The kinetic curve of the change or the end–point of 
fluorescent intensity of EuTc-HP system after incubating 50 - 60 min was record on 
Fluoroskan Ascent fluorescence microplate reader. 
The direct GOx-ELISA process is the same as the sandwich GOx-ELISA except for 
coating with 200 µl diluted bovine IgG to each well and incubate at 37 °C for 1 hour. 
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6.5.2. Coupled GOx-Catalase Enzymatic System 
650 µL of the EuTc stock solution were placed in a cuvette, upon which 40 µL of 
glucose (0.2 M) and 1010 µL of MOPS buffer were added. After fluorescence intensity 
remained constant, the following solutions were sequentially added: 200 µL of H2O2(5 mM), 
5 µL of catalase (1.28x104 U·mL-1), 160 µL of GOx (47.1 U·mL-1), 70 µL of 3-AT (28 mM), 
2.0 µL of a saturated solution of Hg(NO3)2 in MOPS, another 70 µL of 3-AT, and 2 µL of 
catalase, and the time trace of fluorescence intensity monitored as shown in Figure 6.6(A). 
The images, video and animation pictures were obtained by monitoring a similar sequence 
involving addition of a: 650 µL of the EuTc stock solution, 40 µL of glucose (0.2 M) and 
1010 µL of MOPS buffer. b: further addition of 200 µL of H2O2 (5 mM), c: 5 µL of catalase 
(1.28·104 U·mL-1), d: 200 µL of GOx (47.1 U·mL-1), e: 70 µL of 3-AT (28 mM), f: 2.0 µL of 
a saturated solution of Hg(NO3)2 in MOPS, and g: 5 µL of catalase (1.28x104 U·mL-1). The 
images of different stages (a to g in Fig. 6.6(B)) were processed for the histogram and the 
mean values of the red fluorescence intensities as shown in Figure 6.6(B). 
6.5.3. Construction of Microplate Sensors and Arrays 
The microplate sensors and arrays are constructed by the by the immobilization of 
biotinylated glucose oxidase (biotinamidocaproyl labeled GOx) on the streptavidin coated 
microplate (Greiner 96 Well Platte F-form Black, µClear, Streptavidin coated) through the 
biotin-avidin interactions. The composition of the wells in the microplate is specified in Table 
6.1 and 6.2. After the addition of biotinamidocaproyl labeled GOx in streptavidin coated 
plate, shake for 30-45 min. on Miniature Akku-Shaker from Edmund Bühler (KM2, 
www.edmund-buehler.de/english/index.html); then wash with MOPS for three times; finally 
add the other substrates and shake 30-40 min. After reading the plate composition by 
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fluorescence microplate readers, the fluorescence imaging of constructed sensors and arrays is 
performed same as that for GOx alone. 
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7. Materials and Instruments 
7.1. Materials and Reagents 
All inorganic salts were of analytical purity and were obtained from Sigma-Aldrich 
(www.sigmaaldrich.com) unless otherwise stated. All solutions were prepared in a 10 mmol 
L-1 3-(N-morpholino)propanesulfonate (MOPS; from Carl Roth GmbH, www.carl-roth.de) 
buffer of pH 6.9 unless otherwise described. High-purity H2O2 was obtained from Merck 
(www.vwr.com) as a 30% solution. Working concentrations of H2O2 (5 mmol L-1) were 
prepared daily fresh. 
The EuTc reagent was prepared from EuCl3 . 6 H2O (from Alfa Products, 
www.alfa.com) and tetracycline hydrochloride (either from Serva, www.serva.de; or from 
Sigma). The EuTc stock solution was prepared by mixing 10 mL of a 6.3 mM EuCl3 solution 
with 10 mL of a 2.1 mM tetracycline solution in MOPS buffer and diluted to 100 mL. This 
reagent is available from Chromeon GmbH (www.chromeon.com); and it may be further 
diluted to concentration required. Phosphate buffers should be avoided since phosphate binds 
to EuTc. Chlortetracycline hydrochloride, roli-tetracycline hydrochloride, oxytetracycline 
hydrochloride, demeclocycline hydrochloride, doxycycline hydrochloride, minocycline 
hydrochloride, meclocycline sulfosalicylate salt, and glucose were from Sigma-Aldrich. 
Catalase (EC 1.11.1.6, from bovine liver; as a suspension, unit as defined by the 
provider) and 3-amino-1,2,4-triazole, as a specific inhibitor of CAT, were purchased from 
Sigma. Glucose oxidase (GOx, EC 1.1.3.4, from Aspergillus niger, 185,000 unit/g; unit as 
defined by the provider), and other oxidases (Uricase (urate oxidase), galactose oxidase, 
lactate oxidase, sarcosine oxidase) were from Sigma-Aldrich and were used without further 
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purification. The glucose stock solution was stored overnight before use to allow the 
equilibrium of α- and β-anomers. Rabbit anti-bovine IgG, bovine IgG, biotin-conjugated 
monoclonal anti-bovine IgG, biotinamidocaproyl labeled glucose oxidase, streptavidine, and 
bovine serum albumin (BSA), were from Sigma. 
7.2. Instruments 
Quantitative fluorescence measurements were performed on three microplate readers, 
one Fluoroskan Ascent (from Thermo Labsystems, www.labsystems.fi) for steady state 
fluorescence intensity measurement, one GENios+ (from Tecan, www.tecan.com) for time-
resolved (“gated”) detection, and one FLUOstar OPTIMA for time-resolved and rapid 
lifetime determination detections (from BMG Labtechnologies GmbH, www.bmglabtech. 
com). The excitation filters were set to 405 nm, and the emission filters to 620 nm or 612 nm. 
All experiments were performed at a programmed temperature of 30.0 °C.  
Fluorescence spectra and time traces of the coupled GOx-catalase system studies 
were acquired on an SLM AB2 luminescence spectrometer (Spectronic Unicam, 
www.unicaminstruments.com) in rectangular cells with stirring. Varian Eclipse fluorometer 
(Varian, www.varian.com) with microplate accessory has also been appled for the 
fluorescence spectra. Absorption spectra and spectrophotometric detection of catalase were 
performed on a Cary 50 Bio photometer (Varian). 
Circular dichroism (CD) spectra were obtained from J-710 spectropolarimeter (Jasco 
Inc. www.jascoinc.com). Data were processed either with Spectra Manager Software from 
Jasco or with Excel. For videos and photos, a DCR-TRV8E Sony camcorder and an Olympus 
C4040 digital camera were used. 
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Either U-bottom transparent microtiterplates (MTP, microplate), or black Fluotrac 
200, or flat bottom black MTPs with transparent bottom (96 wells; from Greiner bio-one, 
http://www.greiner-lab.com ) were used. In some cases, a Hamilton Microlab dispensing 
robot was used for preparation of the microplates. 
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8. Summary 
The thesis describes the development of a novel reversible H2O2 fluorescent 
probe comprising the ternary complex of europium(III), tetracycline and hydrogen 
peroxide; and its application in the assays of H2O2, of H2O2 producing oxidases and 
their substrates, and of H2O2 consuming catalase and its inhibitors. The probe is 
applied in steady-state intensity-based, time-resolved “gated”, or lifetime-based 
detection modes both for microplate fluorescence measurement and imaging. 
The fluorescent probe’s advantages include the reversibility of the EuTc-HP system, 
the possibility of a kinetic real-time detection of the production and the consumption of H2O2, 
and the system works best at pH 6.9 - 7.0. It also exhibits the typical spectral characteristics of 
a ligand-to-europium energy transfer system which include a Stokes shift of ~210 nm, line-
like emission, excitation at 380-420 nm (e.g. by the 405-nm blue diode laser), and a µs decay 
time (~60 µs) facilitating time-resolved fluorometry and imaging. 
For the probe study, Chapter 1 gives a overview of the state of art of the H2O2 
measurements. In the following first part of Chapter 2 is presented the characterization of the 
fluorescent EuTc-HP probe for its absorbance, circular dichroism and fluorescence spectra, 
fluorescence lifetime and decay profile, optimal pH and stability, and the influence of 
temperature, buffers, quenchers and interferents. In the last part of Chapter 6, the peculiar 
molar ratio of the EuTc-HP probe is further investigated for its possible structure and a com-
binatorial approach for discovery of new lanthanide probes is preliminarily proceeded as well. 
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Different assays have been developed for H2O2, glucose, glucose oxidase and 
catalase, as examples for the detection of enzyme substrates and enzymes. Furthermore, 
different fluorometric schemes have been applied, such as the steady-state intensity-based 
detection (Chapter 5, catalase), the time-resolved gated detections (Chapter 3, glucose), the 
rapid lifetime determination method (Chapter 2, H2O2, novel on microplate) and the time-
correlated single photon counting method of the lifetime-based detection (Chapter 2, H2O2), 
for both microplates and cuvettes, compatible with high-throughput screening. 
The µs range lifetime of the EuTc-HP probe has greatly facilitated fluorescence 
imaging, a means for visualization and mapping of the analyte with multiple chemical 
information. Four schemes of imaging, those are the conventional fluorescence intensity 
imaging (FII), the time-resolved ("gated") imaging (TRI), the phase delay ratioing imaging 
(PDI), and the rapid lifetime determination imaging (RLI), have been tested for the 
quantitative analysis. Hydrogen peroxide, glucose, and glucose oxidase have been determined 
by the fluorescent imaging system, with Chapter 4 highlighting the fluorescence imaging of 
glucose oxidase. 
There are possible further applications in perspective for the EuTc-HP probe. 
Chapter 6 summarizes the initial attempts, such as glucose oxidase based ELISA, the coupled 
catalase/glucose oxidase system as a platform for screening, and the construction of 
microplate arrays and sensors. 
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11. Appendix 
11.1. Abbreviations and Symbols 
3-AT 3-Amino-1,2,4-triazole 
A6550 N-Acetyl-3,7-dihydrophenoxazine 
BOD/COD Biological oxygen demand/ Chemical oxygen demand 
CAT Catalase. 
DELFIA Dissociation enhanced lanthanide fluoroimmunoassay 
DTQ 8-(4,6-Dichloro-1,3,5-triazinoxy)quinoline 
EALL Enzyme-amplified lanthanide luminescence 
ELISA Enzyme-linked immunosorbent assay 
ESR Electron spin resonance 
Eu Europium 
EuTc Europium tetracycline complex, in 3:1 ratio, if not othrewise specified 
EuTc-HP Europium tetracycline hydrogen peroxide complex, usually in 3:1 ratio of 
Eu : Tc. 
FAD Flavin adenine dinucleotide 
FII Fluorescent intensity imaging 
FLIM Fluorescence lifetime imaging microscopy 
GalOx Galactose oxidase 
GFP Green fluorescent protein 
GOx Glucose oxidase 
HP Hydrogen peroxide, H2O2 
HPMQ N-(4'-Hydroxyphenyl)-N-(4-methylquinolinyl)amine 
HST High throughput screening 
IDL Interactive data language 
LOx Lactate oxidase 
MOPS 3-(N-Morpholino)propanesulfonate. 
MTP Microtiter plate, or microplate 
NADH β-Nicotinamide adenine dinucleotide 
PAR 4-(2-Pyridylazo)resorcinol 
PDR, PDI Phase delay ratioing, Phase delay ratioing imaging 
pHPA p-Hydroxyphenylacetate 
POx Peroxidase 
PTQA 2-α-Pyridylthioquinaldinamide 
RLD, RLI Rapid lifetime determination, Rapid lifetime determination imaging 
ROS Reactive oxygen species 
S/N Signal-to-noise ratio 
SCE Saturated calomel electrode 
SOx Sarcosine oxidase 
TBDRH Tris(2,2'-bipyridyl)dichlororuthenium(II) hexahydrate 
Tc Tetracycline 
TCSPC Time-correlated single photon counting 
TRI Time-resolved (gated) imaging 
UOx Urate oxidase 
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11.2. Programs 
A. Matlab codes for imaging processing of GOx images 
1. function [ output_args ] = 
GOx_all1( input_args ) 
2. %GOX_ALL1 Summary of this function 
goes here 
3. clear 
4. %reading the files 
5. g1= imread('GOx_Glu1_img1.tif'); 
6. g2= imread('GOx_Glu1_img2.tif'); 
7. g3= imread('GOx_Glu1_dark1.tif'); 
8. g4= imread('GOx_Glu1_dark2.tif'); 
9.  
10. %crop the file to the interested part 
11. g1a=imcrop(g1,[5 20 315 78]); 
12. g2a=imcrop(g2,[5 20 315 78]); 
13. g3a=imcrop(g3,[5 20 315 78]); 
14. g4a=imcrop(g4,[5 20 315 78]); 
15.  
16. %windows1 subtraction 
17. ga1=imsubtract(g1a,g3a); 
18. ga1b=ga1>10; 
19. ga2=(double(ga1)/65535).*(double 
(ga1b)/255); 
20.  
21. %windows2 subtraction 
22. gb1=imsubtract(g2a,g4a); 
23. gb1b=gb1>10; 
24. gb2=(double(gb1)/65535).*(double 
(gb1b)/255); 
25.  
26. %divide of window1 and windows2 
27. ga3=ga2; 
28. gb3=gb2; 
29. gc=ga3./gb3; 
30.  
31. %further exclude the inf in the array. 
32. gc1=gc<500000; 
33. gd1=gc.*gc1; 
34. gd2=mat2gray(gd1); 
35. imwrite((mat2gray(gd1)),'GOx_RLI_1.ti
f','Compression','none'); 
36. figure, pcolor(mat2gray(gd1)) 
37.  
38. %crop to the targeted dots 
39.     % in the row, upper row 
40. gda12 = imcrop(gd1, [0 0 26 25]); 
41. gda12a= imcrop(gda12, [8 9 15 12]); 
42. a12i=mean2(gda12a); 
43. a12s=std2(gda12a); 
44.  
45. gda11 = imcrop(gd1, [28 0 26 25]); 
46. gda11a= imcrop(gda11, [8 9 15 12]); 
47. a11i=mean2(gda11a); 
48. a11s=std2(gda11a); 
49.  
50. gda10 = imcrop(gd1, [54 0 26 25]); 
51. gda10a= imcrop(gda10, [8 9 15 12]); 
52. a10i=mean2(gda10a); 
53. a10s=std2(gda10a); 
54.  
55. gda9 = imcrop(gd1, [80 0 26 25]); 
56. gda9a= imcrop(gda9, [8 9 15 12]); 
57. a9i=mean2(gda9a); 
58. a9s=std2(gda9a); 
59.  
60. gda8 = imcrop(gd1, [106 0 26 25]); 
61. gda8a= imcrop(gda8, [8 9 15 12]); 
62. a8i=mean2(gda8a); 
63. a8s=std2(gda8a); 
64.  
65. gda7 = imcrop(gd1, [134 0 26 25]); 
66. gda7a= imcrop(gda7, [8 9 15 12]); 
67. a7i=mean2(gda7a); 
68. a7s=std2(gda7a); 
69.  
70. gda6 = imcrop(gd1, [159 0 26 25]); 
71. gda6a= imcrop(gda6, [8 9 15 12]); 
72. a6i=mean2(gda6a); 
73. a6s=std2(gda6a); 
74.  
75. gda5 = imcrop(gd1, [185 0 26 25]); 
76. gda5a= imcrop(gda5, [8 9 15 12]); 
77. a5i=mean2(gda5a); 
78. a5s=std2(gda5a); 
79.  
80. gda4 = imcrop(gd1, [211 0 26 25]); 
81. gda4a= imcrop(gda4, [8 9 15 12]); 
82. a4i=mean2(gda4a); 
83. a4s=std2(gda4a); 
84.  
85. gda3 = imcrop(gd1, [237 0 26 25]); 
86. gda3a= imcrop(gda3, [8 9 15 12]); 
87. a3i=mean2(gda3a); 
88. a3s=std2(gda3a); 
89.  
90. gda2 = imcrop(gd1, [264 0 26 25]); 
91. gda2a= imcrop(gda2, [8 9 14 12]); 
92. a2i=mean2(gda2a); 
93. a2s=std2(gda2a); 
94.  
95. gda1 = imcrop(gd1, [288 0 26 25]); 
96. gda1a= imcrop(gda1, [8 9 14 12]); 
97. a1i=mean2(gda1a); 
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98. a1s=std2(gda1a); 
99.  
100.     % middle row 
101. gdb12 = imcrop(gd1, [0 27 26 25]); 
102. gdb12a= imcrop(gdb12, [8 9 15 12]); 
103. b12i=mean2(gdb12a); 
104. b12s=std2(gdb12a); 
105.  
106. gdb11 = imcrop(gd1, [28 27 26 25]); 
107. gdb11a= imcrop(gdb11, [8 9 15 12]); 
108. b11i=mean2(gdb11a); 
109. b11s=std2(gdb11a); 
110.  
111. gdb10 = imcrop(gd1, [54 27 26 25]); 
112. gdb10a= imcrop(gdb10, [8 9 15 12]); 
113. b10i=mean2(gdb10a); 
114. b10s=std2(gdb10a); 
115.  
116. gdb9 = imcrop(gd1, [80 27 26 25]); 
117. gdb9a= imcrop(gdb9, [8 9 15 12]); 
118. b9i=mean2(gdb9a); 
119. b9s=std2(gdb9a); 
120.  
121. gdb8 = imcrop(gd1, [106 27 26 25]); 
122. gdb8a= imcrop(gdb8, [8 9 15 12]); 
123. b8i=mean2(gdb8a); 
124. b8s=std2(gdb8a); 
125.  
126. gdb7 = imcrop(gd1, [134 27 26 25]); 
127. gdb7a= imcrop(gdb7, [8 9 15 12]); 
128. b7i=mean2(gdb7a); 
129. b7s=std2(gdb7a); 
130.  
131. gdb6 = imcrop(gd1, [159 27 26 25]); 
132. gdb6a= imcrop(gdb6, [8 9 15 12]); 
133. b6i=mean2(gdb6a); 
134. b6s=std2(gdb6a); 
135.  
136. gdb5 = imcrop(gd1, [185 27 26 25]); 
137. gdb5a= imcrop(gdb5, [8 9 15 12]); 
138. b5i=mean2(gdb5a); 
139. b5s=std2(gdb5a); 
140.  
141. gdb4 = imcrop(gd1, [211 27 26 25]); 
142. gdb4a= imcrop(gdb4, [8 9 15 12]); 
143. b4i=mean2(gdb4a); 
144. b4s=std2(gdb4a); 
145.  
146. gdb3 = imcrop(gd1, [237 27 26 25]); 
147. gdb3a= imcrop(gdb3, [8 9 15 12]); 
148. b3i=mean2(gdb3a); 
149. b3s=std2(gdb3a); 
150.  
151. gdb2 = imcrop(gd1, [264 27 26 25]); 
152. gdb2a= imcrop(gdb2, [8 9 14 12]); 
153. b2i=mean2(gdb2a); 
154. b2s=std2(gdb2a); 
155.  
156. gdb1 = imcrop(gd1, [288 27 26 25]); 
157. gdb1a= imcrop(gdb1, [8 9 14 12]); 
158. b1i=mean2(gdb1a); 
159. b1s=std2(gdb1a); 
160.  
161.     %lower row 
162. gdc12 = imcrop(gd1, [0 52 26 25]); 
163. gdc12a= imcrop(gdc12, [8 9 15 12]); 
164. c12i=mean2(gdc12a); 
165. c12s=std2(gdc12a); 
166.  
167. gdc11 = imcrop(gd1, [28 52 26 25]); 
168. gdc11a= imcrop(gdc11, [8 9 15 12]); 
169. c11i=mean2(gdc11a); 
170. c11s=std2(gdc11a); 
171.  
172. gdc10 = imcrop(gd1, [54 52 26 25]); 
173. gdc10a= imcrop(gdc10, [8 9 15 12]); 
174. c10i=mean2(gdc10a); 
175. c10s=std2(gdc10a); 
176.  
177. gdc9 = imcrop(gd1, [80 52 26 25]); 
178. gdc9a= imcrop(gdc9, [8 9 15 12]); 
179. c9i=mean2(gdc9a); 
180. c9s=std2(gdc9a); 
181.  
182. gdc8 = imcrop(gd1, [106 52 26 25]); 
183. gdc8a= imcrop(gdc8, [8 9 15 12]); 
184. c8i=mean2(gdc8a); 
185. c8s=std2(gdc8a); 
186.  
187. gdc7 = imcrop(gd1, [133 52 26 25]); 
188. gdc7a= imcrop(gdc7, [8 9 15 12]); 
189. c7i=mean2(gdc7a); 
190. c7s=std2(gdc7a); 
191.  
192. gdc6 = imcrop(gd1, [159 52 26 25]); 
193. gdc6a= imcrop(gdc6, [8 9 15 12]); 
194. c6i=mean2(gdc6a); 
195. c6s=std2(gdc6a); 
196.  
197. gdc5 = imcrop(gd1, [185 52 26 25]); 
198. gdc5a= imcrop(gdc5, [8 9 15 12]); 
199. c5i=mean2(gdc5a); 
200. c5s=std2(gdc5a); 
201.  
202. gdc4 = imcrop(gd1, [211 52 26 25]); 
203. gdc4a= imcrop(gdc4, [8 9 15 12]); 
204. c4i=mean2(gdc4a); 
205. c4s=std2(gdc4a); 
206.  
207. gdc3 = imcrop(gd1, [237 52 26 25]); 
208. gdc3a= imcrop(gdc3, [8 9 15 12]); 
209. c3i=mean2(gdc3a); 
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210. c3s=std2(gdc3a); 
211.  
212. gdc2 = imcrop(gd1, [264 52 26 25]); 
213. gdc2a= imcrop(gdc2, [8 9 14 12]); 
214. c2i=mean2(gdc2a); 
215. c2s=std2(gdc2a); 
216.  
217. gdc1 = imcrop(gd1, [288 52 26 25]); 
218. gdc1a= imcrop(gdc1, [8 9 14 12]); 
219. c1i=mean2(gdc1a); 
220. c1s=std2(gdc1a); 
221.  
222. % Further caculation of the ratios: 
223. B=[a1i a12i a11i a10i a9i a8i a7i a6i 
a5i a4i a3i a2i;b1i b12i b11i b10i b9i b8i 
b7i b6i b5i b4i b3i b2i; c1i c12i c11i c10i 
c9i c8i c7i c6i c5i c4i c3i c2i]; 
224. C=[a1s a12s a11s a10s a9s a8s a7s 
a6s a5s a4s a3s a2s;b1s b12s b11s b10s 
b9s b8s b7s b6s b5s b4s b3s b2s; c1s c12s 
c11s c10s c9s c8s c7s c6s c5s c4s c3s 
c2s]; 
225. D= mean(B); 
226. E=std(B); 
227. F= mean(C); 
228.  
229. A=[0 0.05412 0.1353 0.2706 0.5412 
1.353 2.706 5.412 13.53 27.06 54.12 
135.3]; 
230. % Glucose conc. A=[0 0.001386 
0.002772 0.00693 0.01386 0.02772 
0.0693 0.1386 0.2772 0.693] 
231.  
232. S=[A D E F]; 
233.  
234. save GOx_Ratio.out S -ASCII 
235.  
236. %regional filtration for 3D graphs 
237. h2=fspecial('average',12); 
238. ga1b1=ga1>10; 
239. gg1=roifilt2(h2,gd1,ga1b1); 
240. gg2=mat2gray(gg1); 
241. gg3=imcrop(gg2,[6.5 6.5 300 65]); 
242. %imwrite((gg2,'Glu_RLI_For3D.tif',
'Compression','none'); 
243. %figure, surf(gg3) 
244.  
245. % invert the color 
246. f1=200; k1=256; k=k1/f1; 
247. [m,n]=size(gg3); 
248. X2=double(gg3); 
249. for i=1:m 
250.         for j=1:n 
251.             f=X2(i,j); 
252.             gg4(i,j)=0; 
253.             if(f>=0)&(f<=f1) 
254.             gg4(i,j)=k1-k*f; 
255.             else 
256.             gg4(i,j)=0; 
257.             end 
258.         end 
259. end 
260.  
261. %crop to the targeted dots 
262.     % in the row, upper row 
263.  
264. gga12 = imcrop(gg4, [0 0 26 25]); 
265. gga12a= imcrop(gga12, [8 6 3 2]); 
266. ga12i=(mean2(gga12a)-254.72)*10; 
267. ga12s=std2(gga12a); 
268.  
269. gga11 = imcrop(gg4, [27 0 26 25]); 
270. gga11a= imcrop(gga11, [8 6 3 2]); 
271. ga11i=(mean2(gga11a)-254.72)*10; 
272. ga11s=std2(gga11a); 
273.  
274. gga10 = imcrop(gg4, [54 0 26 25]); 
275. gga10a= imcrop(gga10, [8 6 3 2]); 
276. ga10i=(mean2(gga10a)-254.72)*10; 
277. ga10s=std2(gga10a); 
278.  
279. gga9 = imcrop(gg4, [80 0 26 25]); 
280. gga9a= imcrop(gga9, [8 6 3 2]); 
281. ga9i=(mean2(gga9a)-254.72)*10; 
282. ga9s=std2(gga9a); 
283.  
284. gga8 = imcrop(gg4, [106 0 26 25]); 
285. gga8a= imcrop(gga8, [8 6 3 2]); 
286. ga8i=(mean2(gga8a)-254.72)*10; 
287. ga8s=std2(gga8a); 
288.  
289. gga7 = imcrop(gg4, [133 0 26 25]); 
290. gga7a= imcrop(gga7, [8 6 3 2]); 
291. ga7i=(mean2(gga7a)-254.72)*10; 
292. ga7s=std2(gga7a); 
293.  
294. gga6 = imcrop(gg4, [159 0 26 25]); 
295. gga6a= imcrop(gga6, [8 6 3 2]); 
296. ga6i=(mean2(gga6a)-254.72)*10; 
297. ga6s=std2(gga6a); 
298.  
299. gga5 = imcrop(gg4, [185 0 26 25]); 
300. gga5a= imcrop(gga5, [8 6 3 2]); 
301. ga5i=(mean2(gga5a)-254.72)*10; 
302. ga5s=std2(gga5a); 
303.  
304. gga4 = imcrop(gg4, [211 0 26 25]); 
305. gga4a= imcrop(gga4, [8 6 3 2]); 
306. ga4i=(mean2(gga4a)-254.72)*10; 
307. ga4s=std2(gga4a); 
308.  
309. gga3 = imcrop(gg4, [237 0 26 25]); 
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310. gga3a= imcrop(gga3, [8 6 3 2]); 
311. ga3i=(mean2(gga3a)-254.72)*10; 
312. ga3s=std2(gga3a); 
313.  
314. gga2 = imcrop(gg4, [264 0 26 25]); 
315. gga2a= imcrop(gga2, [8 6 3 2]); 
316. ga2i=(mean2(gga2a)-254.72)*10; 
317. ga2s=std2(gga2a); 
318.  
319. gga1 = imcrop(gg4, [287 0 26 25]); 
320. gga1a= imcrop(gga1, [8 7 3 2]); 
321. ga1i=(mean2(gga1a)-254.72)*10; 
322. ga1s=std2(gga1a); 
323.  
324.   % middle row 
325. ggb12 = imcrop(gg4, [0 28 26 25]); 
326. ggb12a= imcrop(ggb12, [8 6 3 2]); 
327. gb12i=(mean2(ggb12a)-254.72)*10; 
328. gb12s=std2(ggb12a); 
329.  
330. ggb11 = imcrop(gg4, [27 28 26 25]); 
331. ggb11a= imcrop(ggb11, [8 6 3 2]); 
332. gb11i=(mean2(ggb11a)-254.72)*10; 
333. gb11s=std2(ggb11a); 
334.  
335. ggb10 = imcrop(gg4, [54 28 26 25]); 
336. ggb10a= imcrop(ggb10, [8 6 3 2]); 
337. gb10i=(mean2(ggb10a)-254.72)*10; 
338. gb10s=std2(ggb10a); 
339.  
340. ggb9 = imcrop(gg4, [80 28 26 25]); 
341. ggb9a= imcrop(ggb9, [8 6 3 2]); 
342. gb9i=(mean2(ggb9a)-254.72)*10; 
343. gb9s=std2(ggb9a); 
344.  
345. ggb8 = imcrop(gg4, [106 28 26 25]); 
346. ggb8a= imcrop(ggb8, [8 6 3 2]); 
347. gb8i=(mean2(ggb8a)-254.72)*10; 
348. gb8s=std2(ggb8a); 
349.  
350. ggb7 = imcrop(gg4, [133 28 26 25]); 
351. ggb7a= imcrop(ggb7, [8 6 3 2]); 
352. gb7i=(mean2(ggb7a)-254.72)*10; 
353. gb7s=std2(ggb7a); 
354.  
355. ggb6 = imcrop(gg4, [159 28 26 25]); 
356. ggb6a= imcrop(ggb6, [8 6 3 2]); 
357. gb6i=(mean2(ggb6a)-254.72)*10; 
358. gb6s=std2(ggb6a); 
359.  
360. ggb5 = imcrop(gg4, [185 28 26 25]); 
361. ggb5a= imcrop(ggb5, [8 6 3 2]); 
362. gb5i=(mean2(ggb5a)-254.72)*10; 
363. gb5s=std2(ggb5a); 
364.  
365. ggb4 = imcrop(gg4, [211 28 26 25]); 
366. ggb4a= imcrop(ggb4, [8 6 3 2]); 
367. gb4i=(mean2(ggb4a)-254.72)*10; 
368. gb4s=std2(ggb4a); 
369.  
370. ggb3 = imcrop(gg4, [237 28 26 25]); 
371. ggb3a= imcrop(ggb3, [8 6 3 2]); 
372. gb3i=(mean2(ggb3a)-254.72)*10; 
373. gb3s=std2(ggb3a); 
374.  
375. ggb2 = imcrop(gg4, [264 28 26 25]); 
376. ggb2a= imcrop(ggb2, [8 6 3 2]); 
377. gb2i=(mean2(ggb2a)-254.72)*10; 
378. gb2s=std2(ggb2a); 
379.  
380. ggb1 = imcrop(gg4, [287 28 26 25]); 
381. ggb1a= imcrop(ggb1, [8 6 3 2]); 
382. gb1i=(mean2(ggb1a)-254.72)*10; 
383. gb1s=std2(ggb1a); 
384.  
385.     %lower row 
386. ggc12 = imcrop(gg4, [0 54 26 25]); 
387. ggc12a= imcrop(ggc12, [7 6 3 2]); 
388. gc12i=(mean2(ggc12a)-254.72)*10; 
389. gc12s=std2(ggc12a); 
390.  
391. ggc11 = imcrop(gg4, [27 52 26 25]); 
392. ggc11a= imcrop(ggc11, [7 6 3 2]); 
393. gc11i=(mean2(ggc11a)-254.72)*10; 
394. gc11s=std2(ggc11a); 
395.  
396. ggc10 = imcrop(gg4, [54 52 26 25]); 
397. ggc10a= imcrop(ggc10, [7 6 3 2]); 
398. gc10i=(mean2(ggc10a)-254.72)*10; 
399. gc10s=std2(ggc10a); 
400.  
401. ggc9 = imcrop(gg4, [80 52 26 25]); 
402. ggc9a= imcrop(ggc9, [8 6 3 2]); 
403. gc9i=(mean2(ggc9a)-254.72)*10; 
404. gc9s=std2(ggc9a); 
405.  
406. ggc8 = imcrop(gg4, [106 52 26 25]); 
407. ggc8a= imcrop(ggc8, [8 6 3 2]); 
408. gc8i=(mean2(ggc8a)-254.72)*10; 
409. gc8s=std2(ggc8a); 
410.  
411. ggc7 = imcrop(gg4, [132 52 26 25]); 
412. ggc7a= imcrop(ggc7, [7 6 3 2]); 
413. gc7i=(mean2(ggc7a)-254.72)*10; 
414. gc7s=std2(ggc7a); 
415.  
416. ggc6 = imcrop(gg4, [159 52 26 25]); 
417. ggc6a= imcrop(ggc6, [8 6 3 2]); 
418. gc6i=(mean2(ggc6a)-254.72)*10; 
419. gc6s=std2(ggc6a); 
420.  
421. ggc5 = imcrop(gg4, [185 52 26 25]); 
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422. ggc5a= imcrop(ggc5, [8 6 3 2]); 
423. gc5i=(mean2(ggc5a)-254.72)*10; 
424. gc5s=std2(ggc5a); 
425.  
426. ggc4 = imcrop(gg4, [211 52 26 25]); 
427. ggc4a= imcrop(ggc4, [8 6 3 2]); 
428. gc4i=(mean2(ggc4a)-254.72)*10; 
429. gc4s=std2(ggc4a); 
430.  
431. ggc3 = imcrop(gg4, [237 52 26 25]); 
432. ggc3a= imcrop(ggc3, [8 6 3 2]); 
433. gc3i=(mean2(ggc3a)-254.72)*10; 
434. gc3s=std2(ggc3a); 
435.  
436. ggc2 = imcrop(gg4, [264 52 26 25]); 
437. ggc2a= imcrop(ggc2, [8 6 3 2]); 
438. gc2i=(mean2(ggc2a)-254.72)*10; 
439. gc2s=std2(ggc2a); 
440.  
441. ggc1 = imcrop(gg4, [287 54 26 25]); 
442. ggc1a= imcrop(ggc1, [8 6 3 2]); 
443. gc1i=(mean2(ggc1a)-254.72)*10; 
444. gc1s=std2(ggc1a); 
445.  
446. % Further caculation of the ratioes: 
447. GB=[ga1i ga12i ga11i ga10i ga9i ga8i ga7i 
ga6i ga5i ga4i ga3i ga2i;gb1i gb12i gb11i gb10i 
gb9i gb8i gb7i gb6i gb5i gb4i gb3i gb2i; gc1i 
gc12i gc11i gc10i gc9i gc8i gc7i gc6i gc5i gc4i 
gc3i gc2i] 
448. GC=[ga1s ga12s ga11s ga10s ga9s ga8s 
ga7s ga6s ga5s ga4s ga3s ga2s;gb1s gb12s gb11s 
gb10s gb9s gb8s gb7s gb6s gb5s gb4s gb3s gb2s; 
gc1s gc12s gc11s gc10s gc9s gc8s gc7s gc6s 
gc5s gc4s gc3s gc2s] 
449. GD= mean(GB) 
450. GE=std(GB) 
451. GF= mean(GC) 
452. GS=[A GD GE GF] 
453.  
454. save GOx_Ratio_afterreverse.out GS -
ASCII 
455.  
456. gg5=mat2gray(gg4); 
457. %imwrite((gg5,'Glu_RLI_For3D_fin.tif','Co
mpression','none'); 
458. figure,imshow(gg5) 
459. %figure, surf(gg5) 
460. pixval on 
 
B. Source codes for filling microplates with the Hamilton Microlab dispensing robot 
Number  Line 
    1     
    2                                       Program for hydrogen peroxide detection 
    4    Initialise single needle arm 
    5    Initialise dispenser 1 
   6    Open Excel :C:\...\Methods\Meng\HP\Well_composition_HP_Test3.xls 
    8     Dispensing MOPS from A1 to C9 
    9          Loop 9 
   10           zeile=_sysloop[1]+1 
   11           Read from Excel : Sheet1 
   12                   vol=3*mops 
   13                 Aspirate 5 + vol ul from Polymer with syringe  1 , speed  50 seconds per stroke 
   14              Loop 3 
   15                Dispense  mops ul to  Meng_HP1 with syringe  1 , speed  30 seconds per stroke 
   16            End of loop 
   17     Wash needle with syringe  1, 5 mm above bottom in Waschen, 0 ul 1 times, lift 20 mm 
   18         End of loop 
   19    Wash needle with syringe  1, 5 mm above bottom in Waschen, 1000 ul 2 times, lift 20 mm 
   21     Dispensing MOPS from D1 to F9 
   22          Loop 9 
   23           zeile=_sysloop[1]+10 
   24           Read from Excel : Sheet1 
   25                   vol=3*mops 
   26                Aspirate 5 + vol ul from Polymer with syringe  1 , speed  50 seconds per stroke 
   27              Loop 3 
   28                Dispense  mops ul to  Meng_HP2 with syringe  1 , speed  30 seconds per stroke 
11. Appendix Programs 
 123 
   29            End of loop 
   30     Wash needle with syringe  1, 5 mm above bottom in Waschen, 0 ul 1 times, lift 20 mm 
   31         End of loop 
   32  Wash needle with syringe  1, 5 mm above bottom in Waschen, 1000 ul 2 times, lift 20 mm 
   35    Set new position in Proben to 1 for single needle arm 
   36    Set new position in Meng_HP1 to 1 for single needle arm 
   37    Set new position in Meng_HP2 to 1 for single needle arm 
   40     Dispensing of HP4 
   41    Loop 6 
   42           zeile=_sysloop[1]+1 
   43           Read from Excel : Sheet1 
   44                   vol2=3*HP4+10 
   45                Aspirate 5 + vol2 ul from Proben with syringe  1 , speed  50 seconds per stroke 
   46           Loop 3 
   47                 Dispense  HP4 ul to  Meng_HP1 with syringe  1 , speed  30 seconds per stroke 
   48           End of loop 
   49     Wash needle with syringe  1, 5 mm above bottom in Waschen, 0 ul 1 times, lift 20 mm 
   50    End of loop 
   51  Wash needle with syringe  1, 5 mm above bottom in Waschen, 1000 ul 2 times, lift 20 mm 
   54    Set new position in Proben to old position plus 1 for single needle arm 
   56     Dispensing of HP3 
   57    Loop 3 
   58           zeile=_sysloop[1]+7 
   59           Read from Excel : Sheet1 
   60                   vol3=3*HP3+10 
   61                 Aspirate 5 + vol3 ul from Proben with syringe  1 , speed  50 seconds per stroke 
   62           Loop 3 
   63                 Dispense  HP3 ul to  Meng_HP1 with syringe  1 , speed  30 seconds per stroke 
   64           End of loop 
   65       Wash needle with syringe  1, 5 mm above bottom in Waschen, 0 ul 1 times, lift 20 mm 
   66    End of loop 
   67  Wash needle with syringe  1, 5 mm above bottom in Waschen, 1000 ul 2 times, lift 20 mm 
   70    Set new position in Proben to old position plus 1 for single needle arm 
   72     Dispensing of HP2 
   73    Loop 6 
   74           zeile=_sysloop[1]+10 
   75           Read from Excel : Sheet1 
   76                   vol4=3*HP2+10 
   77                 Aspirate 5 + vol4 ul from Proben with syringe  1 , speed  50 seconds per stroke 
   78           Loop 3 
   79                 Dispense  HP2 ul to  Meng_HP2 with syringe  1 , speed  30 seconds per stroke 
   80           End of loop 
   81     Wash needle with syringe  1, 5 mm above bottom in Waschen, 0 ul 1 times, lift 20 mm 
   82    End of loop 
   83  Wash needle with syringe  1, 5 mm above bottom in Waschen, 1000 ul 2 times, lift 20 mm 
   85    Set new position in Proben to old position plus 1 for single needle arm 
   87     Dispensing of HP1 
   88    Loop 3 
   89           zeile=_sysloop[1]+16 
   90           Read from Excel : Sheet1 
   91                   vol5=3*HP1+10 
   92                 Aspirate 5 + vol5 ul from Proben with syringe  1 , speed  50 seconds per stroke 
   93           Loop 3 
   94                 Dispense  HP1 ul to  Meng_HP2 with syringe  1 , speed  30 seconds per stroke 
   95           End of loop 
   96     Wash needle with syringe  1, 5 mm above bottom in Waschen, 0 ul 1 times, lift 20 mm 
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   97    End of loop 
   98  Wash needle with syringe  1, 5 mm above bottom in Waschen, 1000 ul 2 times, lift 20 mm 
  102    Set new position in Polymer to 2 for single needle arm 
  103    Set new position in Meng_HP1 to 1 for single needle arm 
  104    Set new position in Meng_HP2 to 1 for single needle arm 
  107     Dispensing of EuTc for  A1 to C9 
  108             Aspirate 5 + 1900 ul from Polymer with syringe  1 , speed  50 seconds per stroke 
  109            Loop 27 
  110                   Dispense  65 ul to  Meng_HP1 with syringe  1 , speed  30 seconds per stroke 
  111            End of loop 
  112    Wash needle with syringe  1, 5 mm above bottom in Waschen, 0 ul 1 times, lift 20 mm 
  114    Dispensing of EuTc for  D1 to F9 
  115             Aspirate 5 + 1900 ul from Polymer with syringe  1 , speed  50 seconds per stroke 
  116            Loop 27 
  117                   Dispense  65 ul to  Meng_HP2 with syringe  1 , speed  30 seconds per stroke 
  118            End of loop 
  119  Wash needle with syringe  1, 5 mm above bottom in Waschen, 1000 ul 2 times, lift 20 mm 
  120    Initialise single needle arm 
  121    End of method 
Layout of the excel-worksheet for filling microtiterplates 
 MOPS HP1 HP2 HP3 HP4 EuTc HP (mM) 
A1 185    0 65 0 
A2 180    5 65 0.00001 
A3 175    10 65 0.00002 
A4 165    20 65 0.00004 
A5 145    40 65 0.00008 
A6 105    80 65 0.00016 
A7 165   20  65 0.0004 
A8 145   40  65 0.0008 
A9 125   60  65 0.0012 
D1 185  0   65 0 
D2 180  5   65 0.001 
D3 175  10   65 0.002 
D4 145  40   65 0.008 
D5 125  60   65 0.012 
D6 105  80   65 0.016 
D7 145 40    65 0.08 
D8 125 60    65 0.12 
D9 105 80    65 0.16 
 
 Conc. HP1: 0.5mM, HP2: 0.05mM, HP3: 0.005mM, HP4: 0.0005mM, 
  EuTc: 0.2 mM, MOPS: 10 mM, pH 6.9. 
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11.3. Chinese Summary  
博士论文 
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 本论文研究和发展了一种基于铕-四环素-过氧化氢三元络合物并具有可逆性的荧光探
针. 该探针的突出优点在于 (1) 其可逆性, 可以实现动态实时检测过氧化氢的生成与消耗. (2)  
6.9-7.0 的最佳 pH, 尤其适合生物测定的要求. (3) 具有镧系元素荧光的三大特征, 即较大的
Stokes 位移(~210nm), 线性尖锐发射光谱和较长的微秒级荧光寿命; 并且可在 380-420 nm 范
围内激发 (如可使用 405 nm 半导体蓝色激光),极大地方便了时间分辨荧光检测和荧光影像测
定. 因此该荧光探针可被用于稳态荧光强度测定法, 时间分辨驰预测定法, 和荧光寿命测定法
等检测技术和相对应的多种荧光影像技术. 
 基于过氧化氢的荧光探针在生物研究领域有着广泛的应用前景. 因为过氧化氢作为活
性氧物质(reactive oxygen species, ROS) 的一员, 普遍存在于生物体系中并参与了很多重要的
氧化还原反应, 成为细胞氧化的生物标志物和新的神经递质而受到重视. 
 在本论文中, 首先研究的是探针特性. 第一章对目前的过氧化氢分析技术作了简单的概
述, 第二章的前半部分则主要讨论了该探针的表征, 包括其吸收光谱, 园二色光谱, 荧光光谱, 
荧光寿命和衰变. 同时还讨论了其最佳的 pH, 稳定性, 温度, 缓冲溶剂, 猝灭和干扰的影响等问
题. 第六章的后半部分进一步讨论了该荧光探针特别的结构特征,  并提供了用组合化学的方
式研究新型镧系荧光探针结构的初步结果. 
 其次是测定方法的研究. 多种不同荧光分析原理和测定方法分别用于过氧化氢, 葡萄糖, 
葡萄糖氧化酶, 过氧化氢酶的测定. 如稳态荧光强度测定法测定过氧化物酶 (第五章), 时间分
辨驰预测定法测定葡萄糖 (第三章), 荧光寿命测定法中的快速寿命测定法 (Rapid Lifetime 
Determination, RLD) 测定过氧化氢 (第二章, 首次在微点滴板 (microtiter plate)上实现), 及时间
相关单光子计数测定法检测过氧化氢 (第二章). 这些测定方法既适用于比色池(cuvette), 又适
用于微点滴板 (microtiter plate) 检测, 还可用于高通量筛选研究. 
 另外对基于该探针的荧光影像技术也做了进一步的研究. 由于该荧光探针具有微秒级
荧光寿命, 因此其荧光影像装置被大大简化, 还可以同时使用多种时间分辨的手段获取被测物
的多重信息. 四种影像分析方式, 包括常规荧光影像, 时间分辨驰预, 相驰预比例法(Phase delay 
ratioing PDR) 影像,及快速寿命测定法(RLD) 影像, 被应用于过氧化氢, 葡萄糖, 葡萄糖氧化酶
的荧光影像测定, 其中重点在第四章介绍了葡萄糖氧化酶的荧光影像. 
 最后, 在第六章的前半部分总结了该探针在其他领域中的应用, 包括葡萄糖氧化酶酶标
免疫分析(ELISA), 过氧化氢酶/葡萄糖氧化酶酶联体系用于筛选平台的研究, 及基于微点滴板
的阵列和传感器的研究. 
 
注明: 中文摘要仅供参考, 具体内容以英文原文为准. 
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